Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1050.Time spend outdoors in summer,49897,0.0476172951046877,0.0218231043253887,0.00484401062692581,0.0903905795824495,0.0291228549531906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1060.Time spent outdoors in winter,47747,-0.0166204996039147,0.0240915883293662,-0.0638400127294724,0.0305990135216431,0.490272934518448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1070.Time spent watching television (TV),50681,0.10298706842588,0.0216691209623076,0.0605155913397573,0.145458545512003,2.01970797101104e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1080.Time spent using computer,47766,0.0452066120215226,0.0217321107942239,0.00261167486484376,0.0878015491782015,0.037522660833363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X1090.Time spent driving,45084,0.0688425189618845,0.0239771077557358,0.0218473877606424,0.115837650163127,0.00409467497232489
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1160.Sleep duration,51731,-0.010474831110909,0.0196259466645637,-0.0489416865734539,0.0279920243516359,0.593537900359588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,35899,-0.00975656335775251,0.0237119983109428,-0.0562320800472004,0.0367189533316954,0.680746588373758
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,35899,0.0166390545035627,0.0262293737337934,-0.0347705180146723,0.0680486270217978,0.525861088004129
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,35899,0.0487821590508037,0.0277679367860161,-0.00564299704978777,0.103207315151395,0.0789972229133794
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,35899,0.00876216482923292,0.0284340854715181,-0.0469686426949426,0.0644929723534085,0.757971600834215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,35899,0.0155303557177809,0.0291144782897916,-0.0415340217302105,0.0725947331657724,0.593756486317172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,35899,-0.036394226630287,0.0764377557663918,-0.186212227932415,0.113423774671841,0.633996780762003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,35899,-0.0680876966865655,0.0925053132422054,-0.249398110641288,0.113222717268157,0.461729442725361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,35899,-0.0537286740833621,0.0458511497804277,-0.143596927653,0.0361395794862761,0.241313011321223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,35899,0.0161708345460783,0.0350925252981371,-0.0526105150382705,0.0849521841304271,0.644951764260514
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,35899,0.0177803630572377,0.0238835598833087,-0.0290314143140473,0.0645921404285228,0.456621994415408
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#18.Location of pain during the past week_Upper back,35899,0.0425541361764715,0.0378657796279821,-0.0316627918943734,0.116771064247316,0.261128419499761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#19.Location of pain during the past week_Lower back,35899,0.00244317326950337,0.0177488523377888,-0.0323445773125628,0.0372309238515695,0.890518886256316
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,35899,-0.0351079807675217,0.0244922328770481,-0.083112757206536,0.0128967956714927,0.151776896906976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,35899,-0.0164421893112636,0.0387435415155981,-0.0923795306818359,0.0594951520593086,0.671297350659915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,35899,-0.0370062541935651,0.0359988289418007,-0.107563958919494,0.0335514505323642,0.303990973786235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,35899,0.0585364886162705,0.0442012265743531,-0.0280979154694615,0.145170892702003,0.185438856033545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,35899,0.0193133855435247,0.0436328441738751,-0.0662069890372705,0.10483376012432,0.658043518212673
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#7.Location of pain during the past week_Left hip,35899,-0.0043250785102281,0.0272732911924396,-0.0577807292474098,0.0491305722269536,0.874001863344973
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#8.Location of pain during the past week_Right hip,35899,0.00520353972695233,0.0266691111371693,-0.0470679181018996,0.0574749975558042,0.845308464956293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,35899,0.0423501692897286,0.0294969052054746,-0.0154637649130017,0.100164103492459,0.151116463811404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120040.Fatigue severity over the past week,35904,0.109638694422091,0.0363626900133738,0.0383678219958786,0.180909566848304,0.00257741528622428
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120041.Waking unrefreshed severity over the past week,35907,0.0564024232048179,0.0360284068136358,-0.0142132541499083,0.127018100559544,0.117509342469625
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120042.Cognitive symptoms severity over the past week,35907,0.0281112877252782,0.0397804380755828,-0.0498583709028642,0.10608094635342,0.479799654197946
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120098.Mobility problems today,35909,0.0181047481137869,0.0423563736839994,-0.064913744306852,0.101123240534426,0.669072511080006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120099.Self-care problems today,35909,-0.0273320576658671,0.0647416791632553,-0.154225748825847,0.0995616334941133,0.672912649656624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120100.Problems doing usual activities,35909,-0.00345829949470293,0.0409223545986169,-0.0836661145079921,0.0767495155185862,0.932654213878963
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120101.Pain or discomfort today,35909,-0.00495525855344262,0.0361211704549913,-0.0757527526452256,0.0658422355383404,0.890888877104256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120102.Anxiety or depression today,35909,0.0324722559729524,0.0463550099164011,-0.0583835634631937,0.123328075409099,0.483629715183712
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120103.Scale to indicate how health is today,35892,0.000801694937311273,0.00776711681838868,-0.0144218540267305,0.0160252439013531,0.917793949956937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,35894,0.0288555034532846,0.0452412460919164,-0.0598173388868715,0.117528345793441,0.523614744252588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",35892,0.0151114329578927,0.0483179417180237,-0.0795917328094336,0.109814598725219,0.754479603324984
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",35897,0.0390702793824251,0.0365922184899386,-0.0326504688578545,0.110791027622705,0.285681723390858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,35902,0.054897173926939,0.0373479126651429,-0.0183047348967411,0.128099082750619,0.141635727619528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,35901,0.0781829560682479,0.0530361518924635,-0.0257679016409806,0.182133813777476,0.140485793220476
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120109.Feeling bad about self over the last two weeks,35886,0.0292702724018117,0.0509895449260522,-0.0706692356532505,0.129209780456874,0.565955352834971
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120110.Trouble concentrating over the last two weeks,35905,0.0371995917642848,0.0484165849285103,-0.0576969146955954,0.132096098224165,0.44231996079037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,35897,-0.0121948436325239,0.0716028155591192,-0.152536362128398,0.12814667486335,0.864769223869196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,35862,0.0666517862616628,0.0975758327825609,-0.124596845992157,0.257900418515482,0.494580119989265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33139,0.000415919381840068,0.0514936116543431,-0.100511559460672,0.101343398224352,0.993555826671307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49261,0.0426693238476772,0.0479748472370057,-0.0513613767368539,0.136700024432208,0.373792960705525
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48051,0.0594254944358707,0.0276322574786437,0.00526626977772909,0.113584719094012,0.0315213233175073
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1289.Cooked vegetable intake,50816,0.00915322306414449,0.0205713971083598,-0.0311667152682407,0.0494731613965297,0.656360928483566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1299.Salad  or  raw vegetable intake,49992,-0.0710668006433387,0.0211378311581769,-0.112496949713365,-0.029636651573312,0.000774969195277678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1309.Fresh fruit intake,50671,0.0531340671233117,0.0217503827006496,0.0105033170300384,0.095764817216585,0.0145774521282055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1319.Dried fruit intake,49690,-0.0507993570892057,0.0233046953029544,-0.0964765598829962,-0.0051221542954151,0.0292840049737686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X134.Number of self-reported cancers,51876,0.000580725146253692,0.0433654521834777,-0.0844155611333625,0.0855770114258699,0.989315623873099
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X135.Number of self-reported non-cancer illnesses,51877,0.121319299137785,0.0206079112671451,0.0809277930541802,0.161710805221389,3.98601464681161e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X136.Number of operations, self-reported",51877,0.0483996978267958,0.0197939362493989,0.00960358277797404,0.0871958128756176,0.0144854247543313
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X137.Number of treatments or medications taken,51877,0.142016355005725,0.0202347810774168,0.102356184093988,0.181676525917462,2.30535610373908e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1438.Bread intake,51337,0.00824074186911533,0.00421193334738273,-1.4647491754817e-05,0.0164961312299855,0.0504158711217955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1458.Cereal intake,50685,0.0676908156224581,0.0204270669034012,0.0276537644917918,0.107727866753124,0.000921917550617839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1488.Tea intake,51013,0.0121495461210409,0.00414238733013476,0.00403046695397673,0.020268625288105,0.00336063489339356
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1498.Coffee intake,50066,0.0139058413835218,0.0205529860970697,-0.0263780113667349,0.0541896941337784,0.498676611388064
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X1528.Water intake,49763,-0.0893565901933481,0.0207946142133912,-0.130114034051595,-0.0485991463351013,1.73817518043029e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1568.Average weekly red wine intake,46333,-0.188268442408113,0.0227244768292693,-0.23280841699348,-0.143728467822745,1.26621509439851e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46325,-0.0947346533230855,0.0237857565525115,-0.141354736166008,-0.048114570480163,6.83710582367541e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1588.Average weekly beer plus cider intake,46394,-0.100707597810165,0.0234645759461759,-0.14669816666467,-0.0547170289556603,1.78087644586688e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1598.Average weekly spirits intake,46325,-0.0545272079907057,0.0246768172339179,-0.102893769769185,-0.00616064621222661,0.0271419756221411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1608.Average weekly fortified wine intake,46362,-0.00335473852299049,0.0437126661446766,-0.0890315641665567,0.0823220871205757,0.938827088431436
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X1737.Childhood sunburn occasions,45733,-0.0578040889148965,0.0240366145233817,-0.104915853380725,-0.0106923244490684,0.0161903144059794
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1807.Father's age at death,45939,-0.0126136887159153,0.00481184548198883,-0.0220449058606134,-0.0031824715712172,0.00876503309942573
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1845.Mother's age,37173,-0.00609866520571645,0.0109213289915489,-0.0275044700291523,0.0153071396177194,0.576573660743207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1873.Number of full brothers,51471,0.0251138255407905,0.0197645125442773,-0.013624619045993,0.0638522701275741,0.203865257368296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X1883.Number of full sisters,51473,0.0176923863094022,0.0198914381414761,-0.0212948324478908,0.0566796050666953,0.373772078859864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20015.Sitting height,51677,0.000720544224409515,0.00541895385683503,-0.00990060533498714,0.0113416937838062,0.894220319081676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20016.Fluid intelligence score,36032,-0.05109715300878,0.0327277013110176,-0.115243447578375,0.0130491415608145,0.118500004729587
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20018.Prospective memory result,36377,0.0910152805954005,0.043754422244298,0.00525661299657638,0.176773948194225,0.0375454539662168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35954,0.0103040563088755,0.00738470192659444,-0.0041699594672496,0.0247780720850006,0.162960107594956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35958,0.0195520927320355,0.00740359815323588,0.0050410403516932,0.0340631451123778,0.0082863123258532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20023.Mean time to correctly identify matches,51576,0.00541240834542274,0.00427487667658311,-0.00296634994068015,0.0137911666315256,0.205491209209669
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#1.Illnesses of father_Heart disease,48458,0.0145402169852394,0.00952985544160333,-0.00413829968030315,0.0332187336507819,0.127087015858881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48014,-0.0224185450405626,0.0213353805058393,-0.0642358908320076,0.0193988007508824,0.293378021354132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,47975,0.0366970900382144,0.0280527838313195,-0.0182863662711718,0.0916805463476006,0.190839879917175
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#12.Illnesses of father_Severe depression,47999,0.0298016041671906,0.0251572529434926,-0.0195066116020549,0.0791098199364362,0.236185081766233
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48020,0.015490826004258,0.0169098489685786,-0.0176524779741561,0.0486341299826722,0.359634712897745
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#2.Illnesses of father_Stroke,48193,0.0288945513072033,0.0121134457297615,0.00515219767687085,0.0526369049375358,0.0170733075029555
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48137,-0.0128655358167754,0.0153999986396456,-0.0430495331504809,0.01731846151693,0.403488968993047
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48037,0.0198055032530946,0.0187188916464752,-0.0168835243739967,0.056494530880186,0.290046285061516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48163,0.00770229759547993,0.01437803072147,-0.0204786426186013,0.0358832378095611,0.592172640802895
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48248,0.0126766442383915,0.0107684848909668,-0.0084295861479035,0.0337828746246865,0.239130547984223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20107#9.Illnesses of father_Diabetes,48106,0.0245696064122291,0.0147998922995258,-0.00443818249484146,0.0535773953192996,0.0969062628317167
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49240,0.0266467348188949,0.0113506235597352,0.00439951264181392,0.0488939569959759,0.0189041431717715
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49083,0.000748552277353413,0.0159258620920775,-0.0304661374231185,0.0319632419778254,0.962511846166709
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49006,-0.0089923850171963,0.0353627532562527,-0.0783033813994515,0.0603186113650589,0.799274294739179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49041,0.0555211010873491,0.0188565377093531,0.0185622871770171,0.0924799149976811,0.00323950616348228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#2.Illnesses of mother_Stroke,49184,-0.000913217289722183,0.0126949653698964,-0.0257953494147192,0.0239689148352748,0.942654024433612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49084,-0.000446081970371938,0.0212099720090017,-0.0420176271080152,0.0411254631672713,0.98322056556966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49049,-0.0033936868172021,0.0193298744377504,-0.0412802407151928,0.0344928670807886,0.860635918873138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49058,0.00830984382764553,0.0162145551524925,-0.0234706842712398,0.0400903719265308,0.608311645343151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49088,0.0182989098278936,0.0193505772949769,-0.0196282216702611,0.0562260413260483,0.344337324970572
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49288,0.0215082545251848,0.00978009948382418,0.00233925953688943,0.0406772495134802,0.0278757486287127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49141,0.0374478503783009,0.0147331883889608,0.00857080113593772,0.0663248996206641,0.0110376823007642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46235,0.037845762602489,0.0156287365872977,0.00721343889138547,0.0684780863135925,0.0154645074991136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46091,0.0470454261246336,0.0634408161530443,-0.0772985735353331,0.1713894257846,0.458361491425155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46085,0.0689141051563066,0.0624407690321406,-0.0534698021466891,0.191298012459302,0.26975079647291
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46139,-0.0278327951437614,0.0203400507662774,-0.067699294645665,0.0120337043581423,0.171212589036419
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46101,0.0311178030915439,0.0360350727364676,-0.0395109394719326,0.10174654565502,0.387851306084201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46135,0.0264953316852939,0.0261207615953514,-0.0247013610415949,0.0776920244121826,0.310434568902672
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46105,0.0335666906336841,0.0298279737090648,-0.024896137836083,0.0920295191034511,0.260459297072435
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46109,0.0402602933543656,0.0290794062723604,-0.0167353429394608,0.097255929648192,0.166224573315171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46116,-0.0645305268233109,0.0229753327569366,-0.109562179026907,-0.0194988746197151,0.00497989937853804
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46134,0.0683105966877039,0.0289934876962058,0.0114833608031406,0.125137832572267,0.0184805342414757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46297,-0.0090831470171172,0.0118619936770325,-0.032332654624101,0.0141663605898666,0.443844044472348
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46200,0.0329579147627102,0.016558220435591,0.000503802708951909,0.0654120268164685,0.0465594537367744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20127.Neuroticism score,47366,0.0436095867627102,0.02056714331685,0.00329798586168427,0.0839211876637362,0.0339894484464782
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36032,0.0162552399596545,0.0330562484300122,-0.0485350069631694,0.0810454868824785,0.622914271770573
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X20161.Pack years of smoking,36710,0.0366212183331678,0.00732622460657897,0.022261818104273,0.0509806185620626,5.89424454803288e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36710,0.0380944388775716,0.00722454244118057,0.0239343356928577,0.0522545420622855,1.37732454931547e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20191.Fluid intelligence score,34149,0.0215826204154479,0.0381150222314303,-0.0531228231581555,0.0962880639890514,0.57124698822991
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34150,0.0389785502767917,0.0385822843079456,-0.0366427269667817,0.114599827520365,0.312409765657905
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X20240.Maximum digits remembered correctly,33618,-0.0827121306480566,0.0407620965416974,-0.162605839869783,-0.00281842142632976,0.0424964753464778
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X20255.Spirometry QC measure,45226,0.0176834278315951,0.0252195618552582,-0.0317469134047111,0.0671137690679012,0.483201109321856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X20261.avMSE,33703,-0.00262776447339795,0.00906269123027397,-0.0203906392847349,0.015135110337939,0.771863133967776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X20262.Myopia diagnosis,33703,-0.0072279222458995,0.0504146478706988,-0.106040632072469,0.0915847875806701,0.886004041014448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X20280.Glucose-lactate,41872,0.00838410587168655,0.00527113979735031,-0.00194732813112005,0.0187155398744932,0.111730665819842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X20281.Spectrometer-corrected alanine,41897,0.0190729048213259,0.00559688669506821,0.00810300689899222,0.0300428027436596,0.000656901129834351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35807,0.0105511245536536,0.0348189301216847,-0.0576939784848483,0.0787962275921556,0.761876967412801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35807,0.0234873154548396,0.0774814590804534,-0.128376344342849,0.175350975252528,0.761795993540437
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35807,0.170970144931627,0.0940101186226624,-0.013289687568791,0.355229977432046,0.0690085341034481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35807,-0.0274052575880351,0.0339445413215941,-0.0939365585783596,0.0391260434022895,0.419489266494978
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35807,-0.00175362934879592,0.0478222978680894,-0.0954853331702512,0.0919780744726593,0.970749383326443
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35810,0.0969263016933062,0.0648652189050294,-0.0302095273605514,0.224062130747164,0.135148215970177
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35810,0.0179661548774589,0.0407594674504664,-0.0619224013254552,0.097854711080373,0.65938199330964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35810,0.0523115028865836,0.0470352529071206,-0.0398775928113728,0.14450059858454,0.26609935212403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35810,-0.053342000672622,0.067885147171626,-0.186396889129009,0.079712887783765,0.432029028209045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35810,0.0272168267970322,0.0752272867432389,-0.120228655219716,0.17466230881378,0.717516123234279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35810,0.0524589895829004,0.0490546210929819,-0.0436880677593442,0.148606046925145,0.284925471296608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35810,0.0682844653381329,0.0736784689228611,-0.0761253337506749,0.212694264426941,0.354066619633848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35810,0.0284580019005707,0.0598163264275908,-0.0887819978975072,0.145698001698649,0.634262327675464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35813,0.193625805017399,0.102330332446878,-0.00694164657848148,0.39419325661328,0.0585091003731144
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35813,-0.0479422553736456,0.0448072381606918,-0.135764442168602,0.0398799314213104,0.284670074255623
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35813,-0.0274585681234378,0.058113081748199,-0.141360208349908,0.0864430721030322,0.63658255488689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35813,0.0711917161130906,0.124582348668978,-0.172989687278107,0.315373119504288,0.567717165583305
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20600.Liking for adding salt to foods,36474,-0.0074341264484213,0.0316415751857475,-0.0694516138124864,0.0545833609156438,0.814255169602918
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20601.Liking for aniseed,36474,0.00863821173329902,0.0315084602422455,-0.0531183703415022,0.0703947938081003,0.783972468886094
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20602.Liking for apple juice,36474,0.088120207128924,0.0316196235398147,0.0261457449908871,0.150094669266961,0.00533452106033962
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20603.Liking for apples,36474,0.0416716536062601,0.0326438265330121,-0.0223102463984436,0.105653553610964,0.201796940701652
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20604.Liking for asparagus,36474,-0.101336171552932,0.0318135760476571,-0.16369078060634,-0.038981562499524,0.00145162506449643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20605.Liking for aubergine,36474,-0.138368244165116,0.032043711889712,-0.201173919468951,-0.0755625688612801,1.59302665823807e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20606.Liking for avocados,36474,-0.103174346912565,0.0317507897259828,-0.165405894775491,-0.0409427990496384,0.00116091984827897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20607.Liking for bacon,36474,-0.00286492311068884,0.0321755405973374,-0.0659289826814701,0.0601991364600924,0.929052067538595
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20608.Liking for baked or steamed fish,36474,-0.0308539724615738,0.0320335855244621,-0.0936398000895195,0.0319318551663719,0.335488949081346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20609.Liking for bananas,36474,0.0615519363476746,0.0328209901366164,-0.00277720432009354,0.125881077015443,0.06077703128811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36474,-0.073119421396653,0.0322068702963847,-0.136244887177567,-0.00999395561573899,0.0232160113275376
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20611.Liking for beef steak,36474,-0.0216488035283433,0.0324437408640541,-0.0852385356218893,0.0419409285652028,0.504617912148246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20612.Liking for beetroot,36474,0.0106215544911394,0.0321639245460575,-0.0524197376191333,0.0736628466014121,0.74123352690388
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20613.Liking for bell pepper,36474,-0.059170300504968,0.0321311570437482,-0.122147368310714,0.00380676730077835,0.0655824223715792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20614.Liking for bicycling,36474,-0.0895396831361385,0.0320388932043302,-0.152335913816626,-0.0267434524556514,0.00520707670600879
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20615.Liking for biscuits,36474,0.114019817011772,0.0319406067966827,0.0514162276902743,0.176623406333271,0.000359460236256293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20616.Liking for bitter foods,36474,-0.112325829025487,0.0321227445922412,-0.17528640842628,-0.0493652496246947,0.000473528583009807
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20617.Liking for bitter or ale,36474,-0.154180651540346,0.0321505463346284,-0.217195722356217,-0.0911655807244739,1.65183045676388e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20618.Liking for black olives,36474,-0.112171567061707,0.0321330783836819,-0.175152400693723,-0.0491907334296903,0.00048413847020657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20619.Liking for black pepper,36474,-0.128306851840732,0.0324049996291758,-0.191820651113917,-0.0647930525675475,7.57762493793219e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20620.Liking for blue cheese,36474,-0.083731317347553,0.0319104318504022,-0.146275763774341,-0.0211868709207647,0.00870849219764793
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20621.Liking for bolognese sauce,36474,-0.0173261827794569,0.0321327866385843,-0.0803064445910822,0.0456540790321684,0.589760167580531
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20622.Liking for broad beans,36474,-0.0863637051630396,0.0319959807528462,-0.149075827438618,-0.0236515828874611,0.00696539401967251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20623.Liking for broccoli,36474,-0.0632295538481954,0.0322935171007249,-0.126524847365616,6.57396692255452e-05,0.0502695046195608
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20624.Liking for brown rice,36474,-0.00693055185783236,0.0319047100692861,-0.0694637835936331,0.0556026798779684,0.82803738636248
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20625.Liking for brussel sprouts,36474,-0.0145390437215413,0.0321716014571623,-0.0775953825775793,0.0485172951344968,0.65133787800773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20626.Liking for burgers (meat),36474,0.0186105784233857,0.0318393797458139,-0.0437946058784096,0.0810157627251809,0.558890993243402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20627.Liking for burn of spicy foods,36474,-0.119848424722819,0.0320449298743636,-0.182656487276572,-0.0570403621690663,0.000185318906153046
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20628.Liking for butter on bread,36474,0.0714982835133446,0.0321961952293684,0.00839374086378263,0.134602826162907,0.0263992630100346
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20629.Liking for butternut squash,36474,-0.0563149354434562,0.0314828206453405,-0.118021263908323,0.00539139302141119,0.0736933547723072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20630.Liking for cabbage,36474,-0.0368778837906346,0.0323423613041209,-0.100268911946712,0.0265131443654424,0.254223240795982
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20631.Liking for cake,36474,0.191630600361154,0.0319395182331338,0.129029144624212,0.254232056098096,2.06312267976005e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20632.Liking for cake icing,36474,0.150262093229908,0.0316618927789246,0.0882047833832159,0.2123194030766,2.11314695452504e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20633.Liking for capers,36474,-0.100270383984226,0.032169516120225,-0.163322635579867,-0.0372181323885852,0.00183398781412881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20634.Liking for cauliflower,36474,-0.0521421226884912,0.0319967503632321,-0.114855753400426,0.0105715080234437,0.10322466752614
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20635.Liking for cereal or granola bar,36474,0.0363785574799893,0.0316068342658258,-0.0255708376810292,0.0983279526410079,0.249779054122618
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20636.Liking for cheesecake,36474,0.123491190839361,0.031741434244198,0.0612779797207325,0.185704401957989,0.000100848027629537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20637.Liking for cherries,36474,0.0369607562869539,0.0323844577143864,-0.0265127808332434,0.100434293407151,0.253775037261831
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20638.Liking for chicken,36474,0.0492826829268,0.0331168023675565,-0.0156262497136107,0.114191615567211,0.136752119990193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20639.Liking for chilli pepper,36474,-0.157441856324314,0.0320438820052707,-0.220247865054645,-0.0946358475939838,9.13553142347305e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20640.Liking for chips or french fries,36474,0.042800789730439,0.0323044205979985,-0.0205158746416381,0.106117454102516,0.185236005296018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20641.Liking for cigarette smoking,36474,0.0610918668695251,0.0503120263126164,-0.0375197047032031,0.159703438442253,0.224685020134686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20642.Liking for cod,36474,0.0103903044370985,0.0328598655669724,-0.0540150320741674,0.0747956409483644,0.751858753513278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20643.Liking for coffee with sugar,36474,0.10864026466803,0.0329609848394679,0.0440367343826731,0.173243794953387,0.000984973601837345
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20644.Liking for coffee without sugar,36474,-0.0718747056921444,0.0318950579901782,-0.134389019352894,-0.00936039203139527,0.024256661684044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20645.Liking for coriander,36474,-0.100352092117788,0.0319749706735065,-0.163023034637861,-0.0376811495977152,0.00170467366785932
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20646.Liking for corn flakes,36474,0.14059664749061,0.0315751627041779,0.0787093285904209,0.202483966390798,8.59435038269423e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20647.Liking for cream,36474,0.0882995280145513,0.0317276741904605,0.0261132866012488,0.150485769427854,0.00539799081525494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20648.Liking for croissant,36474,0.0379493133989049,0.0317760083912955,-0.0243316630480344,0.100230289845844,0.232406171679938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20649.Liking for cucumber,36474,-0.022162920700856,0.031935166085527,-0.084755846228489,0.040430004826777,0.487704366219265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20650.Liking for curry,36474,-0.0180613500836036,0.0324766712539079,-0.0817156257412631,0.0455929255740559,0.578135726987423
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20651.Liking for dairy products,36474,0.0762907603429174,0.0326983533572793,0.0122019877626499,0.140379532923185,0.0196643924577102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20652.Liking for dark chocolate,36474,-0.0176583478281753,0.0323194045681843,-0.0810043807818166,0.0456876851254659,0.584827237438799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20653.Liking for diet fizzy drinks,36474,0.112705842195831,0.0323036934700146,0.0493906029946022,0.17602108139706,0.000487583864234255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20654.Liking for dried fruit,36474,0.00865594546291516,0.0321880522910732,-0.0544326370275884,0.0717445279534187,0.787999866972821
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20655.Liking for eggs,36474,0.0367403435309733,0.0327952768658322,-0.0275383991260578,0.101019086188004,0.262622814482599
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20656.Liking for exercising alone,36474,-0.127844815591245,0.031833130080315,-0.190237750548662,-0.0654518806338275,5.9721408680704e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20657.Liking for exercising with others,36474,-0.0663035567740124,0.0315863499279822,-0.128212802632857,-0.00439431091516734,0.0358380676568715
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20658.Liking for extra virgin olive oil,36474,-0.115586936641017,0.0322079055558691,-0.178714431530521,-0.0524594417515139,0.000334256385597361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20659.Liking for fatty foods,36474,0.0318271354857913,0.0316314521801318,-0.030170510787267,0.0938247817588495,0.314356890231061
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20660.Liking for fresh tomatoes,36474,-0.0471761920788159,0.0330408420293413,-0.111936242456325,0.017583858298693,0.153384973094048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20661.Liking for fried chicken,36474,0.0283102375033552,0.0320652583284349,-0.0345376688203771,0.0911581438270876,0.377320305477915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20662.Liking for fried or battered fish,36474,0.0475177943976259,0.0321661479139878,-0.0155278555137901,0.110563444309042,0.139645739269124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20663.Liking for fruit,36474,0.0499806678882102,0.0340286944134975,-0.0167155731622449,0.116676908938665,0.14193244711226
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20664.Liking for garlic,36474,-0.0936525372433618,0.0325454109940797,-0.157441542791758,-0.0298635316949656,0.00401797136283325
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20665.Liking for gherkins,36474,-0.0860873465422438,0.0320017300691031,-0.148810737477686,-0.0233639556068018,0.00715848395466566
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20666.Liking for globe artichoke,36474,-0.107027732526978,0.0323531443131972,-0.170439895380845,-0.0436155696731116,0.000943499998175659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20667.Liking for goat's cheese,36474,-0.0688169695574235,0.0316234236213602,-0.13079887985529,-0.00683505925955749,0.0295745194697194
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20668.Liking for going to a cafe,36474,0.0665540932617246,0.0319604967399406,0.00391151965144103,0.129196666872008,0.0373394600664155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20669.Liking for going to the gym,36474,-0.0582721485155936,0.0314261075788315,-0.119867319370103,0.00332302233891606,0.0637394967793707
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20670.Liking for going to the pub,36474,-0.130245355938835,0.0317717127381872,-0.192517912905682,-0.0679727989719881,4.18367243025495e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20671.Liking for grapefruit,36474,-0.0292189456233104,0.0319817682330437,-0.091903211360076,0.0334653201134552,0.3609484619574
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20672.Liking for green olives,36474,-0.106473210095903,0.0319683236816825,-0.169131124512001,-0.0438152956798052,0.000870628722361382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20673.Liking for haddock,36474,-0.0406573902181342,0.032721055566041,-0.104790659127575,0.0234758786913061,0.214072522514953
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20674.Liking for ham,36474,0.0876703938698979,0.0322811721758273,0.0243992964052764,0.150941491334519,0.00662529491112158
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20675.Liking for hard cheese,36474,-0.0681262914510737,0.0325198489342601,-0.131865195362223,-0.00438738753992388,0.0362105321442193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20676.Liking for herring,36474,-0.0361421106064758,0.0318962426595318,-0.0986587462191582,0.0263745250062067,0.257200508084507
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20677.Liking for honey,36474,0.0831428029095525,0.0319857967257837,0.0204506413270165,0.145834964492089,0.00935705055407998
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20678.Liking for horseradish or wasabi,36474,-0.0847291636848033,0.0321695561313355,-0.147781493702221,-0.0216768336673857,0.00845928703449007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20679.Liking for ice cream,36474,0.139276890067301,0.0323574063356985,0.0758563736493322,0.20269740648527,1.69523572895806e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20680.Liking for jam,36474,0.135947713758722,0.0319021678626033,0.0734194647480197,0.198475962769425,2.05525263960295e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20681.Liking for kiwi fruit,36474,0.010772685057158,0.0318747164945398,-0.0517017592721401,0.0732471293864561,0.735395120163028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20682.Liking for lager,36474,-0.108571066412855,0.0319350788545275,-0.171163820967729,-0.0459783118579807,0.000677844318772206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20683.Liking for lamb,36474,0.0370104335074467,0.0325147446722006,-0.0267184660500664,0.10073933306496,0.255044031802109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20684.Liking for lemons,36474,-0.0852276989611396,0.0321281613046541,-0.148198895118262,-0.0222565028040176,0.00800014050634752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20685.Liking for lentils or beans,36474,-0.0237745992580376,0.0322391009399473,-0.0869632371003343,0.0394140385842591,0.460873108934913
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20686.Liking for liver,36474,0.026478665285502,0.0317987220056109,-0.0358468298454954,0.0888041604164995,0.405041544096099
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20687.Liking for mackerel,36474,-0.0600596071291398,0.0320451784286434,-0.122868156849281,0.00274894259100134,0.0609376100192781
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20688.Liking for marzipan,36474,0.133597685155224,0.0316420130368404,0.0715793396030171,0.195616030707432,2.44695193455775e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20689.Liking for mayonnaise,36474,-0.0541200817931092,0.031842152046015,-0.116530699803299,0.00829053621708012,0.0892388746183414
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20690.Liking for melon,36474,0.0215589878496899,0.0322497710968626,-0.0416505635001609,0.0847685391995407,0.503833786451552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20691.Liking for milk chocolate,36474,0.13645994284296,0.0318052827793655,0.0741215885954037,0.198798297090516,1.80421546489357e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20692.Liking for mushrooms,36474,-0.0432029796104891,0.0328219758116811,-0.107534052201384,0.0211280929804059,0.188117731398536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20694.Liking for orange juice,36474,0.0167414742587359,0.0317661967368059,-0.0455202713454037,0.0790032198628755,0.598193399622012
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20695.Liking for oranges,36474,0.0363015723246287,0.0323849241488517,-0.0271728790071205,0.099776023656378,0.262347424498235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20696.Liking for pasta,36474,0.011135185220589,0.0322491575556864,-0.0520731635885563,0.0743435340297342,0.729888543688599
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20697.Liking for pears,36474,0.0528758312851714,0.0324866603345808,-0.0107980229706069,0.11654968554095,0.103646238975957
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20698.Liking for pizza,36474,0.00417145875651381,0.0321749722930859,-0.0588914869379346,0.0672344044509622,0.896847307388276
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20699.Liking for plain yogurt,36474,-0.0328027878554566,0.0316467072062822,-0.0948303339797698,0.0292247582688566,0.299986428437574
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20700.Liking for plums,36474,0.0345057014176068,0.0322852439884331,-0.0287733767997219,0.0977847796349356,0.285203312686863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20701.Liking for pollock,36474,-0.0142492903594589,0.0318418942274285,-0.0766594030452187,0.048160822326301,0.654525444156969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20702.Liking for pork chop,36474,0.0187643619234133,0.0320080253353848,-0.043971367733941,0.0815000915807676,0.557731547991919
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20703.Liking for porridge,36474,0.0469802016616333,0.031932354433742,-0.015607213028501,0.109567616351767,0.141265853529108
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20704.Liking for potato crisps,36474,0.0633236289124102,0.031899504144274,0.000800600789633149,0.125846657035187,0.0471682941765357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20705.Liking for potatoes,36474,0.0416107874361449,0.0324528541304061,-0.0219968066594511,0.105218381531741,0.199813115335198
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20706.Liking for prawns,36474,-0.0867884909268593,0.0321674450069925,-0.149836683140565,-0.023740298713154,0.00699015708474188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20707.Liking for raw carrots,36474,-0.0149519826196323,0.0320288988752399,-0.0777286244151026,0.047824659175838,0.64063596574999
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20708.Liking for red meat,36474,-0.0272846960773356,0.0321889718439517,-0.0903750808914809,0.0358056887368096,0.396663661337291
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20709.Liking for red wine,36474,-0.200984401173272,0.0320929591692065,-0.263886601144917,-0.138082201201627,3.98574458990103e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36474,0.153268521363093,0.0322024761251431,0.0901516681578127,0.216385374568374,1.97512402471931e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20711.Liking for roast chicken,36474,0.0507503649981567,0.0331541108379786,-0.0142316922442813,0.115732422240595,0.125873572967521
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20712.Liking for salad dressing,36474,-0.0204463662328522,0.0320203313867919,-0.0832062157509644,0.04231348328526,0.523138707180467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20713.Liking for salad leaves,36474,-0.0553418374511216,0.0320497539393988,-0.118159355172343,0.00747568027010012,0.0842522589289564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20714.Liking for salami,36474,-0.0322688283953137,0.0319572339770386,-0.0949050069903093,0.030367350199682,0.312645972964351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20715.Liking for salmon,36474,-0.0631871500574845,0.0325858571851216,-0.127055430140323,0.000681130025353832,0.0525252033080588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20716.Liking for salty foods,36474,0.0297757608654584,0.0315907112596384,-0.0321420332034328,0.0916935549343496,0.34594111231371
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20717.Liking for salty pretzels,36474,-0.0157574928599541,0.0317140769957727,-0.0779170837716686,0.0464020980517604,0.619300854943252
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20718.Liking for sardines,36474,-0.0592263377588566,0.0320858558197151,-0.122114615165498,0.00366193964778493,0.0649485537892713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20719.Liking for sausages (meat),36474,0.0419537273205174,0.0321178333054662,-0.0209972259581964,0.104904680599231,0.191507790142144
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20720.Liking for savoury biscuits,36474,-0.00681555882330801,0.0322420834081017,-0.0700100423031874,0.0563789246565714,0.832590739732878
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36474,-0.118826469300539,0.0317289167262339,-0.181015146083958,-0.0566377925171209,0.000181643861471651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20722.Liking for skimmed milk,36474,0.0609684608971237,0.0318396487063141,-0.00143725056725187,0.123374172361499,0.0555466308599711
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20723.Liking for smoked fish,36474,-0.0253352292321517,0.0319558569021685,-0.087968708760402,0.0372982502960987,0.427906858003981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20724.Liking for soft cheese,36474,-0.0168934255961374,0.0315978996665172,-0.0788253089425111,0.0450384577502363,0.592915583451796
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20725.Liking for soy sauce,36474,-0.0490721081212635,0.031965550557807,-0.111724587214565,0.0135803709720382,0.124785726713786
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20726.Liking for soya milk,36474,-0.0199765832042151,0.0321048165132276,-0.0829020235701412,0.0429488571617111,0.533808613746101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20727.Liking for spicy foods,36474,-0.0664050630072647,0.0324911189729936,-0.130087656194332,-0.00272246982019714,0.0410074214478057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20728.Liking for spinach,36474,-0.0954330560622575,0.0318652574892123,-0.157888960741114,-0.0329771513834014,0.00275395474256499
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20729.Liking for spirits,36474,-0.0595327526858397,0.0321648034144945,-0.122575767378249,0.00351026200656947,0.0642262495190521
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20730.Liking for strawberries,36474,0.0753357036840564,0.0334863396518954,0.00970247796634133,0.140968929401771,0.0244927135878686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36474,0.104205262089756,0.0320533963566717,0.0413806052306793,0.167029918948833,0.0011548820210703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20732.Liking for sweet foods,36474,0.228628860989006,0.0317332109477201,0.166431767531474,0.290825954446537,6.35480033402786e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20733.Liking for taking the stairs,36474,-0.0632412027783732,0.0325817571557653,-0.127101446803673,0.000619041246926785,0.0522939115005026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20734.Liking for tea with sugar,36474,0.118156265354997,0.0347578166166922,0.0500309447862806,0.186281585923714,0.00067865548517232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20735.Liking for tea without sugar,36474,-0.0517475548856025,0.0322310337007701,-0.114920380939112,0.011425271167907,0.10841966028591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20736.Liking for tomato ketchup,36474,0.0765518093672825,0.0317885020296811,0.0142463453891076,0.138857273345457,0.0160560020568406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20737.Liking for tinned tuna,36474,-0.023800769575302,0.0319577524339414,-0.0864379643458271,0.038836425195223,0.456440702051162
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20738.Liking for turnip (white),36474,-0.026187986270041,0.0319515994555584,-0.0888131212029355,0.0364371486628534,0.412460882723385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20739.Liking for vegetables,36474,-0.073437828204786,0.0333579585842688,-0.138819427029953,-0.00805622937961903,0.0277289836865896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20740.Liking for vinegar,36474,0.0101951821658461,0.0321163300263319,-0.0527528246857645,0.0731431890174567,0.750914067601293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20741.Liking for watching television,36474,0.0442366765630174,0.032150558297134,-0.0187784176993652,0.1072517708254,0.168884806027983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20742.Liking for whisky,36474,-0.0782932625661615,0.0323404108456884,-0.141680467823711,-0.0149060573086122,0.0155041488929138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20743.Liking for white bread,36474,0.108502081017902,0.0316560536567447,0.046456215850682,0.170547946185121,0.000612219212814227
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20744.Liking for white rice,36474,0.0451130089113582,0.0319613472557558,-0.0175312317099232,0.10775724953264,0.158140782530314
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20745.Liking for white wine,36474,-0.143114979075139,0.0315999956603642,-0.205050970569453,-0.0811789875808257,6.01494875999548e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36474,6.07080609414508e-05,0.0320423643590262,-0.0627423260827498,0.0628637422046327,0.998488361989409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20747.Liking for whole milk,36474,0.0905004580707597,0.0317201844347223,0.0283288965787039,0.152672019562815,0.00434097259624795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20748.Liking for wholemeal bread,36474,-0.0158561936220267,0.0328668381135096,-0.0802751963245056,0.0485628090804522,0.629508647599373
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X20749.Liking for working up a sweat,36474,-0.137493682725819,0.0321222358888234,-0.200453265067913,-0.0745341003837257,1.88832778537442e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21001.Body mass index (BMI),51743,0.0568727799803938,0.021943360379512,0.0138637936365502,0.0998817663242373,0.00955354974526122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21002.Weight,51774,-0.0129954573521514,0.0105094343598503,-0.033593948697458,0.00760303399315511,0.216266148144427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X21021.Pulse wave Arterial Stiffness index,36366,0.0114645131351029,0.0078937673980227,-0.00400727096502162,0.0269362972352274,0.146444708786936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36231,0.0263753509677681,0.0350897160472491,-0.0424004924848401,0.0951511944203762,0.452281918469624
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36233,-0.0888589283650512,0.035713674109261,-0.158857729619203,-0.0188601271108996,0.012864205013561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36234,-0.0320415766648753,0.0346670011920661,-0.0999888990013249,0.0359057456715744,0.355376372330232
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21040.Satisfaction with bowel habits,36207,0.0396967720312713,0.0323012168992074,-0.0236136130911752,0.103007157153718,0.219126389938911
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36207,0.032945656597775,0.0349108088866764,-0.0354795288201108,0.101370842015661,0.345348203495596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21042.Greatest number of times bowels opened per day,36203,-0.00474875255859793,0.0349479247014652,-0.0732466849734698,0.063749179856274,0.89191909849663
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21043.Least number of times bowels opened per week,36169,-0.0722801824538871,0.0345973591088503,-0.140091006307234,-0.00446935860054039,0.0367246546417092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21044.Average number of times bowels opened per day,36178,0.0149956362105805,0.0381844104385715,-0.0598458082490196,0.0898370806701806,0.694540168537397
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36240,0.000761793942470216,0.035041571865518,-0.0679196869139451,0.0694432747988856,0.982656147485569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36236,-0.00862503258683658,0.0351823602204416,-0.0775824586189022,0.060332393445229,0.806345183968406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36238,0.0531288798637409,0.0408557701535399,-0.0269484296371973,0.133206189364679,0.193502845646183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36238,-0.0592542679879675,0.0507934257372468,-0.158809382432971,0.0403008464570363,0.243419048455438
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36238,-0.0724301085858507,0.0425995556526359,-0.155925237665017,0.0110650204933157,0.0891236827015188
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36237,0.012857716182803,0.10420885916354,-0.191391647777735,0.217107080143341,0.901806195414074
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36240,0.000812305325314554,0.0436820767658835,-0.0848045651358172,0.0864291757864463,0.985163999539844
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36237,-0.114189766337619,0.0395995749889317,-0.191804933315925,-0.0365745993593129,0.00394242737944006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36101,0.0510945834609125,0.0397532014766559,-0.0268216914333332,0.129010858355158,0.198728976571245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36235,-0.0722925910846264,0.0359229752521677,-0.142701622578875,-0.00188355959037782,0.0442093368025634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36239,-0.0380041612005527,0.0608171650419398,-0.157205804682755,0.0811974822816493,0.53206059597795
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36240,-0.140982636653196,0.0354864309554472,-0.210536041325872,-0.0714292319805194,7.16676036911308e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36239,-0.0255236242645673,0.0352127869979237,-0.0945406867804978,0.0434934382513632,0.468572610661317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X21100.Water hardness (USGS classification),51614,-0.0160072311326596,0.0197629238814256,-0.0547425619402537,0.0227280996749346,0.417969990661477
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2139.Age first had sexual intercourse,48827,-0.00236421101676433,0.00428709140517866,-0.0107669101709145,0.00603848813738584,0.581316224406285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2149.Lifetime number of sexual partners,47169,-0.0711150533835446,0.0228019464982203,-0.115806868520056,-0.0264232382470328,0.00181857615773649
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22032.IPAQ activity group,48058,-0.164208017821144,0.0218758378099719,-0.207084659928689,-0.121331375713599,6.34089511040818e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22033.Summed days activity,48457,-0.0317195599898217,0.00422637831618492,-0.0400032614895441,-0.0234358584900992,6.39488383221116e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22034.Summed minutes activity,48058,-0.0344904601489798,0.00427127639914483,-0.0428621618913036,-0.0261187584066559,7.13882834791004e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22037.MET minutes per week for walking,47350,-0.023834146235392,0.00437233401081578,-0.032403920896591,-0.0152643715741931,5.0683412032248e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22038.MET minutes per week for moderate activity,48058,-0.0238965771328514,0.00434004100062158,-0.0324030574940697,-0.0153900967716332,3.71568561743888e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22039.MET minutes per week for vigorous activity,48058,-0.186913426987066,0.021965665228543,-0.22996613083501,-0.143860723139122,1.87422600570054e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X22040.Summed MET minutes per week for all activity,47350,-0.0337476187628311,0.00432935448996864,-0.0422331535631696,-0.0252620839624926,6.77228852117632e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X2217.Age started wearing glasses or contact lenses,48095,-0.0119867126204778,0.00445364602749105,-0.0207158588343602,-0.00325756640659532,0.00712053966002609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X22501.Year ended full time education,34068,-0.06076848496127,0.020166187538345,-0.100294212536426,-0.0212427573861139,0.00259534927260465
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X22506.Tobacco smoking,34031,-0.133555756699468,0.0770822754201965,-0.284637016523053,0.0175255031241172,0.0832166417710266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,50426,-0.0446597167265914,0.0623906465755358,-0.166945384014642,0.0776259505614589,0.474117641425619
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23098.Weight,51338,-0.0132133791702289,0.0106205453955642,-0.0340296481455347,0.007602889805077,0.213463159349195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23099.Body fat percentage,51307,0.0666878866375813,0.00947564695986732,0.0481156185962413,0.0852601546789212,2.00827532447913e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23100.Whole body fat mass,51268,0.0546038962012608,0.0094708068984634,0.0360411146802725,0.0731666777222491,8.24751444306619e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23101.Whole body fat-free mass,51332,-0.0386863235300761,0.00914581249763157,-0.056612116025434,-0.0207605310347182,2.34658461602763e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23102.Whole body water mass,51338,-0.039157441551136,0.00912354509221013,-0.0570395899318678,-0.0212752931704041,1.77874522745604e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23104.Body mass index (BMI),51338,0.059896441474025,0.0216787475728221,0.0174060962312938,0.102386786716756,0.00573344958219467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23105.Basal metabolic rate,51338,-0.0380045687434946,0.00950612280920587,-0.0566365694495381,-0.0193725680374511,6.41075123550251e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23106.Impedance of whole body,51338,0.0463831085025292,0.00749186105880567,0.0316990608272701,0.0610671561777883,6.07554980832558e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23107.Impedance of leg (right),51338,0.0380995261434849,0.00606359412228543,0.0262148816638054,0.0499841706231643,3.3742072132021e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23108.Impedance of leg (left),51338,0.0359136056024018,0.0060470329141374,0.0240614210906925,0.0477657901141111,2.90852867449735e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23109.Impedance of arm (right),51338,0.0296262318682617,0.00742176031911484,0.0150795816427966,0.0441728820937267,6.57776250714257e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23110.Impedance of arm (left),51338,0.029710732221504,0.00740912498439036,0.0151888472520989,0.0442326171909091,6.09077089557564e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23111.Leg fat percentage (right),51338,0.0661428668246321,0.0096465586907687,0.0472356117907255,0.0850501218585388,7.23106802820217e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23112.Leg fat mass (right),51338,0.052416523609114,0.0104039584935328,0.0320247649617898,0.0728082822564382,4.73695086515796e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23113.Leg fat-free mass (right),51337,-0.0475057369570695,0.0100550512314363,-0.0672136373706847,-0.0277978365434543,2.31987073005975e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23114.Leg predicted mass (right),51337,-0.0485692722141674,0.010127452990031,-0.0684190800746282,-0.0287194643537066,1.63049814418741e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23115.Leg fat percentage (left),51337,0.0640693752551238,0.0101070499577852,0.0442595573378649,0.0838791931723827,2.35485891975579e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23116.Leg fat mass (left),51337,0.0480202640044806,0.0110248800981961,0.0264114990120162,0.0696290289969449,1.33267018655081e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23117.Leg fat-free mass (left),51336,-0.0440409904376757,0.0109426215029865,-0.0654885285835292,-0.0225934522918222,5.72277792489635e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23118.Leg predicted mass (left),51336,-0.0443605418164791,0.0110284685972,-0.065976340266991,-0.0227447433659672,5.78024689715762e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23119.Arm fat percentage (right),51336,0.0573429316310208,0.0106470686987853,0.0364746769814016,0.0782111862806401,7.28406508597292e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23120.Arm fat mass (right),51335,0.0414825773469546,0.0116539309864473,0.018640872613518,0.0643242820803913,0.000372269160879235
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23121.Arm fat-free mass (right),51334,-0.0339696859851825,0.0100383854067845,-0.05364492138248,-0.0142944505878849,0.000715640812714294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23122.Arm predicted mass (right),51334,-0.0323426900121569,0.0100830035399002,-0.0521053769503613,-0.0125800030739526,0.00134012201529187
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23123.Arm fat percentage (left),51332,0.0513574796314642,0.010018263723146,0.0317216827340981,0.0709932765288303,2.97777514956057e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23124.Arm fat mass (left),51332,0.0342657780212718,0.0111966329823263,0.0123203773759123,0.0562111786666312,0.00221325399853989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23125.Arm fat-free mass (left),51328,-0.0308362290233728,0.00914247358650893,-0.0487554772529303,-0.0129169807938153,0.000745174911493259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23126.Arm predicted mass (left),51327,-0.0309011075474923,0.00919393972116417,-0.048921229400974,-0.0128809856940105,0.000777802606393119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23127.Trunk fat percentage,51325,0.0533851797102708,0.00801144256723021,0.0376827522784996,0.0690876071420421,2.73285152369568e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23128.Trunk fat mass,51325,0.0494084833912966,0.008451116359296,0.0328442953270764,0.0659726714555167,5.09239151063729e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23129.Trunk fat-free mass,51324,-0.0315995089063181,0.00792743248147061,-0.0471372765700005,-0.0160617412426357,6.73790610096302e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X23130.Trunk predicted mass,51322,-0.0308994426618597,0.0079217109105169,-0.0464259960464728,-0.0153728892772466,9.62298339138772e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23400.Total Cholesterol,41900,-0.0665094665027749,0.00558043440940812,-0.0774471179452149,-0.055571815060335,1.3916761797667e-32
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,41900,-0.0125176134124141,0.0054835149302546,-0.0232653026757131,-0.00176992414911512,0.022459520679088
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",41900,0.00599753776492498,0.00551504889632011,-0.00481195807186243,0.0168070336017124,0.276841845366818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23403.VLDL Cholesterol,41900,0.0701183787740155,0.00565590149640286,0.0590328118410659,0.0812039457069651,4.21902047352853e-35
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23404.Clinical LDL Cholesterol,41900,-0.034867394114102,0.00546327339745066,-0.0455754099731053,-0.0241593782550987,1.80419355111318e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23405.LDL Cholesterol,41900,-0.0281412662266004,0.00544149821468339,-0.0388066027273798,-0.0174759297258209,2.35465358870236e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23406.HDL Cholesterol,41900,-0.216931137050057,0.00590922752123889,-0.228513222991685,-0.205349051108429,4.08399673879444e-281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23407.Total Triglycerides,41900,0.120708325797385,0.00568075999889976,0.109574036199542,0.131842615395229,1.46381726000608e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23408.Triglycerides in VLDL,41900,0.127787440554181,0.00575737638564334,0.11650298283832,0.139071898270042,3.3227424432147e-107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23409.Triglycerides in LDL,41900,0.0856188424908826,0.00539693549266673,0.0750408489252558,0.0961968360565093,3.65988177163494e-56
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23410.Triglycerides in HDL,41900,0.0662523355775012,0.00562039198649916,0.0552363672839628,0.0772683038710395,6.49930530206427e-32
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,41900,-0.0661981083260645,0.00560828788354251,-0.0771903525778078,-0.0552058640743211,5.39932552156761e-32
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23412.Phospholipids in VLDL,41900,0.104350205868805,0.00567623855760856,0.0932247782958924,0.115475633441718,1.48417961139106e-74
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23413.Phospholipids in LDL,41900,-0.0197336793716084,0.00546427925067222,-0.0304436667029259,-0.00902369204029081,0.000305673488064361
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23414.Phospholipids in HDL,41900,-0.1621811226516,0.00577302075967392,-0.173496243340561,-0.15086600196264,9.59133458149387e-169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23415.Total Esterified Cholesterol,41900,-0.0778354173823095,0.0055990659324729,-0.0888095866099564,-0.0668612481546626,1.25215905782481e-43
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,41900,0.0528903236122221,0.00563790147301316,0.0418400367251163,0.0639406104993279,7.56423989749848e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23417.Cholesteryl Esters in LDL,41900,-0.0186240938767085,0.00544422097439635,-0.0292947669865254,-0.00795342076689168,0.000626036605109455
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23418.Cholesteryl Esters in HDL,41900,-0.224931587511495,0.00589119389425059,-0.236478327544226,-0.213384847478763,9.21356831447111e-303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23419.Total Free Cholesterol,41900,-0.0376914724149477,0.00553302223723332,-0.048536195999925,-0.0268467488299704,1.00324471272667e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23420.Free Cholesterol in VLDL,41900,0.0907254261358096,0.00567232854751017,0.0796076621826896,0.10184319008893,4.75562771196298e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23421.Free Cholesterol in LDL,41900,-0.0527186410498712,0.00545330914386922,-0.0634071269718548,-0.0420301551278875,4.90714702843607e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23422.Free Cholesterol in HDL,41900,-0.176685944432703,0.00597560078360915,-0.188398121968577,-0.164973766896829,3.80300676596221e-186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,41900,-0.0165362374108859,0.00541801812671309,-0.0271555529392435,-0.00591692188252822,0.00227708051028651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23424.Total Lipids in VLDL,41900,0.112096573886624,0.00566948441542035,0.1009843844324,0.123208763340848,8.82350310491543e-86
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23425.Total Lipids in LDL,41900,-0.0194305531590632,0.0054457686689394,-0.0301042597501844,-0.00875684656794193,0.000360969103105782
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23426.Total Lipids in HDL,41900,-0.180491200970226,0.00583152603078368,-0.191920991990562,-0.16906140994989,3.61035389637812e-203
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,41900,-0.158436827108251,0.00555821896241806,-0.16933093627459,-0.147542717941911,1.58390378991702e-173
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23428.Concentration of VLDL Particles,41900,0.0843421709058057,0.00562855877285495,0.0733101957110101,0.0953741461006014,2.38023325660416e-50
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23429.Concentration of LDL Particles,41900,0.0176243557923564,0.00547397455110978,0.00689536567218125,0.0283533459125316,0.00128649320758134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23430.Concentration of HDL Particles,41900,-0.170759144212232,0.00553399753062266,-0.181605779372252,-0.159912509052211,5.53124137136995e-202
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23431.Average Diameter for VLDL Particles,41900,0.130770980639245,0.00584530833394914,0.119314176304705,0.142227784973785,7.43554190527816e-109
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23432.Average Diameter for LDL Particles,41900,-0.0684833878525747,0.00560132719536259,-0.0794619891554854,-0.057504786549664,3.43305880205591e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23433.Average Diameter for HDL Particles,41900,-0.144121461182727,0.00609965163932861,-0.156076778395811,-0.132166143969643,6.08569663117853e-121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23434.Phosphoglycerides,41891,-0.0809589327804873,0.00560318060730299,-0.0919411667708012,-0.0699766987901735,5.79107555719676e-47
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,41891,0.191379630374061,0.00586129223214182,0.179891497599063,0.202867763149059,5.20655101789994e-225
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23436.Total Cholines,41891,-0.094295902539226,0.0056844064533762,-0.105437339187843,-0.0831544658906087,3.47383616600156e-61
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23437.Phosphatidylcholines,41891,-0.100414026238738,0.00569669162104317,-0.111579541815983,-0.0892485106614935,9.28826890536443e-69
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23438.Sphingomyelins,41891,-0.0922147747557356,0.00574066885321041,-0.103466485708028,-0.0809630638034432,1.60069679995873e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23439.Apolipoprotein B,41900,0.0199271174293106,0.00549298166972267,0.00916087335665419,0.030693361501967,0.000286981638569542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23440.Apolipoprotein A1,41900,-0.176953769442192,0.00570171445797561,-0.188129129779824,-0.16577840910456,3.15388827557426e-204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,41900,0.111133300347209,0.00552664136450258,0.100301083272784,0.121965517421634,1.27970610771506e-88
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23442.Total Fatty Acids,41891,0.03066024619337,0.00527424848194299,0.0203227191687617,0.0409977732179782,6.26979315706695e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23443.Degree of Unsaturation,41891,-0.121548406201967,0.00562948504462377,-0.13258219688943,-0.110514615514505,1.19582114811572e-101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23444.Omega-3 Fatty Acids,41891,-0.0224986587805801,0.00554879898847001,-0.0333743047979813,-0.0116230127631789,5.04871003272551e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23445.Omega-6 Fatty Acids,41891,-0.0237961096451026,0.00546135384678856,-0.0345003631848082,-0.0130918561053971,1.32736384458401e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,41891,-0.0264432656733126,0.00548334340841945,-0.0371906187538147,-0.0156959125928104,1.43361911366503e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23447.Monounsaturated Fatty Acids,41891,0.076345406738847,0.00534232524844423,0.0658744492518963,0.0868163642257977,5.48060614648053e-46
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23448.Saturated Fatty Acids,41891,0.0333306837148877,0.00520337818914264,0.0231320624641681,0.0435293049656072,1.54838949168981e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23449.Linoleic Acid,41891,-0.0105319818156164,0.00545510670752081,-0.0212239909623572,0.000160027331124352,0.0535457792941792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23450.Docosahexaenoic Acid,41891,-0.0897349980051981,0.0054583676989576,-0.100433398695155,-0.0790365973152412,3.88265455836405e-60
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,41891,-0.04733962336151,0.00556253404564137,-0.0582421900909671,-0.0364370566320529,1.91689091978467e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,41891,-0.0973959976683796,0.00540301875464245,-0.107985914427479,-0.0868060809092804,8.66717073903387e-72
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,41891,-0.118062737632426,0.00550885722898389,-0.128860097801234,-0.107265377463617,3.34814151760249e-100
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,41891,0.156676896258507,0.00572353718066228,0.145458763384409,0.167895029132605,1.51227298281664e-160
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,41891,0.0278444204979262,0.00509176452650896,0.0178645620259686,0.0378242789698837,4.62005328101685e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,41891,-0.0707703381449075,0.00556985210428178,-0.0816872482692998,-0.0598534280205152,8.96437363376884e-37
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,41891,-0.106833752579687,0.00538702999591773,-0.117392331371686,-0.0962751737876885,2.79335652740979e-86
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,41891,-0.147248904502304,0.00568747418974356,-0.158396353914201,-0.136101455090407,3.14569850878465e-144
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,41891,0.0145244529124553,0.00550315612805429,0.00373826690146888,0.0253106389234417,0.00831755782191808
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23460.Alanine,41897,0.00974779597901004,0.00549298696668453,-0.00101845847569163,0.0205140504337117,0.0759885973996558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23461.Glutamine,41856,-0.0533323641576119,0.00535799024510904,-0.0638340250380256,-0.0428307032771982,2.92915357820749e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23462.Glycine,41886,-0.00557163822458291,0.00653254503116321,-0.0183754264856628,0.00723215003649697,0.393727541792869
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23463.Histidine,41883,0.000346298114096224,0.0054362415925271,-0.0103087354072569,0.0110013316354493,0.949208668172677
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),41891,0.0448458968415741,0.00608472432580539,0.0329198371629956,0.0567719565201527,1.80374909452856e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23465.Isoleucine,41898,0.053209119673168,0.00586175316568864,0.0417200834684183,0.0646981558779178,1.26731789993784e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23466.Leucine,41898,0.0300331584330988,0.00604108645466311,0.0181926289819591,0.0418736878842385,6.72706571395322e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23467.Valine,41891,0.0450549106735762,0.006042960511869,0.033210708070313,0.0568991132768394,9.48738625071902e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23468.Phenylalanine,41892,0.0270918413715512,0.00559043248538527,0.016134593700196,0.0380490890429063,1.27328681291207e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23469.Tyrosine,41886,0.0205037760175474,0.00578312560860322,0.0091688498246851,0.0318387022104097,0.000393292892547719
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23470.Glucose,41878,-0.00256544739877456,0.00527854970533138,-0.0129114048212241,0.00778051002367494,0.626965482834381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23471.Lactate,41879,0.0158113318719422,0.00557859521413006,0.00487728525224726,0.0267453784916371,0.00459975774866579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23472.Pyruvate,41854,-0.0355446098239915,0.00531732015308479,-0.0459665573240377,-0.0251226623239453,2.40684892185093e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23473.Citrate,41897,0.00950227250737448,0.0055490618435434,-0.00137388870597058,0.0203784337207195,0.0868443357268344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23474.3-Hydroxybutyrate,41626,0.0163830180653645,0.00611312188299374,0.00440129917469681,0.0283647369560323,0.00737201003486261
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23475.Acetate,41888,-0.0284522603144457,0.00526870679369665,-0.0387789256300911,-0.0181255949988003,6.76983042806105e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23476.Acetoacetate,41899,0.0232592368258826,0.00554705839346604,0.0123870023746892,0.0341314712770761,2.76979104425361e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23477.Acetone,41899,-0.0471183540100337,0.00550182869204536,-0.0579019382464426,-0.0363347697736248,1.2077204200709e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23478.Creatinine,41642,0.056683434535081,0.00660901723438919,0.0437297607556782,0.0696371083144838,1.08583078398096e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23479.Albumin,41898,-0.0760623995792165,0.00543946551958391,-0.0867237519976009,-0.065401047160832,4.03879989246135e-44
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23480.Glycoprotein Acetyls,41900,0.14521274226084,0.00558252014594286,0.134271002774792,0.156154481746888,1.52989606933428e-145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,41900,0.136501822316048,0.0056820471484868,0.125365009905014,0.147638634727082,7.1161143400294e-125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,41900,0.132116506474272,0.0056549337597214,0.121032836305218,0.143200176643326,2.41540370270677e-118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,41900,0.141907502044406,0.0058361746161488,0.130468599796754,0.153346404292057,8.18774716257691e-128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,41900,0.133260843138151,0.00575552070025342,0.121980022565654,0.144541663710648,2.63031336120033e-116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,41900,0.132473740589747,0.00576054227583482,0.12118307772911,0.143764403450383,8.58815024833371e-115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,41900,0.130595503668166,0.00571588866759339,0.119392361879683,0.141798645456649,2.3067226522418e-113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,41900,0.126848371131192,0.00554731276047796,0.115975638120655,0.137721104141728,1.52333419348595e-113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,41900,0.142324872249618,0.00592931649244627,0.130703411924423,0.153946332574812,1.12237772269865e-124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,41900,0.139991458610226,0.00588669699025654,0.128453532509323,0.151529384711129,1.85665902929008e-122
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,41900,0.142669500224538,0.00587928102701011,0.131146109411599,0.154192891037478,2.54457705762205e-127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,41900,0.127389266906524,0.00587253755692156,0.115879093294958,0.138899440518091,1.43790387960906e-102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,41900,0.112835268478534,0.00588833548274293,0.101294130932358,0.12437640602471,9.29552010169933e-81
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,41900,0.137700586432803,0.0058373607309683,0.126259359400105,0.149141813465501,1.45139395243268e-120
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,41900,0.139724788828517,0.00590156068566739,0.128157729884609,0.151291847772425,2.03922797616377e-121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23495.Concentration of Large VLDL Particles,41900,0.131745043618302,0.00585698051309752,0.120265361812631,0.143224725423973,5.32597137585899e-110
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23496.Total Lipids in Large VLDL,41900,0.12724215832063,0.00584733137343312,0.115781388828701,0.138702927812559,3.41646718470683e-103
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23497.Phospholipids in Large VLDL,41900,0.138649771495732,0.00594598598782623,0.126995638959592,0.150303904031871,6.61314593802093e-118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23498.Cholesterol in Large VLDL,41900,0.12285187302719,0.00590271747858876,0.111282546769156,0.134421199285224,1.06397552185786e-94
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,41900,0.107839559001412,0.00588101558004261,0.0963127684645287,0.119366349538296,3.4393085478456e-74
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,41900,0.134685889309402,0.005939282828246,0.12304489496604,0.146326883652764,9.7738978185141e-112
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23501.Triglycerides in Large VLDL,41900,0.119998571353384,0.00577457586738801,0.108680402653304,0.131316740053465,2.04090065116547e-94
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,41900,0.0587514209124797,0.00560133487411942,0.0477728045592056,0.0697300372657538,1.22418034475498e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23503.Total Lipids in Medium VLDL,41900,0.0717434306556157,0.00560563977036905,0.0607563767056924,0.082730484605539,2.77554836242968e-37
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23504.Phospholipids in Medium VLDL,41900,0.0540973933097985,0.00558941156148957,0.043142146649279,0.0650526399703181,4.39853900005831e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23505.Cholesterol in Medium VLDL,41900,0.00348139153634571,0.00550771605530384,-0.00731373193204982,0.0142765150047412,0.527336645205893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,41900,-0.0225759688390006,0.00548721213104061,-0.0333309046158402,-0.011821033062161,3.90716104006443e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,41900,0.0383276053671794,0.00556974607859158,0.0274109030531399,0.0492443076812189,6.19249694276426e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23508.Triglycerides in Medium VLDL,41900,0.105304136816377,0.0057220289686731,0.0940889600377777,0.116519313594976,1.04322303437927e-74
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23509.Concentration of Small VLDL Particles,41900,0.100504064737076,0.00574428326875196,0.089245269530322,0.11176285994383,8.75547978649953e-68
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23510.Total Lipids in Small VLDL,41900,0.0925573321357302,0.0057584220505866,0.0812708249165804,0.10384383935488,1.36606871928397e-57
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23511.Phospholipids in Small VLDL,41900,0.0607447515513477,0.00567330129726218,0.0496250810087139,0.0718644220939816,1.20998597779955e-26
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23512.Cholesterol in Small VLDL,41900,0.0562686067335278,0.00572517244221192,0.0450472687467924,0.0674899447202631,1.01643756179933e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,41900,0.0709253358950348,0.00581712091013649,0.0595237789111672,0.0823268928789023,5.17486185946346e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,41900,0.0314063793403391,0.00558038223925981,0.0204688301513899,0.0423439285292883,1.85996848017223e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23515.Triglycerides in Small VLDL,41900,0.118698324805136,0.00577061042261259,0.107387928376815,0.130008721233457,1.41267804297348e-92
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,41900,0.0425157705133413,0.00554207693520207,0.0316532997203452,0.0533782413063373,1.81864814001363e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,41900,0.0445015086573644,0.00557987554575097,0.0335649525876925,0.0554380647270363,1.64293486314279e-15
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,41900,0.0627349949708066,0.00554922323277551,0.0518585174345666,0.0736114725070466,1.68621903093934e-29
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,41900,-0.001408474460169,0.00562549636025074,-0.0124344473262604,0.00961749840592245,0.802302491795169
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,41900,-0.0170835736731904,0.00566262013430262,-0.0281823091364236,-0.00598483820995732,0.00255854642827612
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,41900,0.0354177661131898,0.00557097200328905,0.0244986609867433,0.0463368712396364,2.11685946603574e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,41900,0.106688188419738,0.0056158548938881,0.0956811128277171,0.117695264011758,2.00156267584464e-79
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23523.Concentration of IDL Particles,41900,-0.0106993798639577,0.00550353379912116,-0.0214863061102352,8.75463823197288e-05,0.0519053325454818
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23524.Total Lipids in IDL,41900,-0.0478857645360804,0.00560491935070293,-0.0588714064634582,-0.0369001226087027,1.44241619129266e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23525.Phospholipids in IDL,41900,-0.035960459306935,0.00560806215004832,-0.0469522611210297,-0.0249686574928402,1.48205682238195e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23526.Cholesterol in IDL,41900,-0.0641513091121504,0.00562151948140328,-0.0751694872957009,-0.0531331309286,5.03930720267185e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23527.Cholesteryl Esters in IDL,41900,-0.0661968822242395,0.0056269849737908,-0.0772257727728695,-0.0551679916756095,8.58036412240488e-32
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23528.Free Cholesterol in IDL,41900,-0.056635462556944,0.00558719006995083,-0.0675863550940477,-0.0456845700198404,4.64545984026081e-24
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23529.Triglycerides in IDL,41900,0.0838194671865925,0.00545141440600689,0.073134694950819,0.094504239422366,6.78572431546e-53
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23530.Concentration of Large LDL Particles,41900,0.00913772038461376,0.00545049459440068,-0.00154524902041157,0.0198206897896391,0.0936650119590183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23531.Total Lipids in Large LDL,41900,-0.0374143081063116,0.00546346079365099,-0.0481226912618676,-0.0267059249507557,7.81261751930837e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23532.Phospholipids in Large LDL,41900,-0.0398699721263627,0.00547914933031577,-0.0506091048137816,-0.0291308394389438,3.61332524291219e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23533.Cholesterol in Large LDL,41900,-0.0452244364259089,0.00546118786469127,-0.0559283646407038,-0.034520508211114,1.33664894178594e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,41900,-0.0384503860499275,0.00545776152332041,-0.0491475986356355,-0.0277531734642195,1.94471198574054e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23535.Free Cholesterol in Large LDL,41900,-0.062637543441945,0.00549310920957654,-0.0734040374927151,-0.051871049391175,5.57069517132767e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23536.Triglycerides in Large LDL,41900,0.0765086729052131,0.00539848397362178,0.0659276443169144,0.0870897014935118,2.9043469648005e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23537.Concentration of Medium LDL Particles,41900,0.024121581175021,0.00550759212026489,0.0133267006193018,0.0349164617307401,1.19753479010172e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23538.Total Lipids in Medium LDL,41900,0.0060842388059408,0.00547645301458187,-0.00464960910263967,0.0168180867145213,0.266596331651856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23539.Phospholipids in Medium LDL,41900,0.00257351260480069,0.00549824297253073,-0.00820304362135954,0.0133500688309609,0.639748702690479
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23540.Cholesterol in Medium LDL,41900,-0.000391014948302476,0.00546832840282024,-0.0111089386178301,0.0103269087212252,0.942996611076272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,41900,0.0137108661053888,0.0054884523226391,0.00295349955301617,0.0244682326577614,0.0124970255757641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,41900,-0.037955517613247,0.00542964710485309,-0.0485976259387591,-0.027313409287735,2.87134705488877e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23543.Triglycerides in Medium LDL,41900,0.0913203265708509,0.00542073385640928,0.0806956882122887,0.101944964929413,5.00631007337672e-63
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23544.Concentration of Small LDL Particles,41900,0.0407059652616036,0.00550603873178374,0.0299141293473075,0.0514978011758997,1.52166896574491e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23545.Total Lipids in Small LDL,41900,0.0209843748156164,0.00543673157018056,0.0103283809380625,0.0316403686931703,0.000114043949869136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23546.Phospholipids in Small LDL,41900,0.0205159112966283,0.00541993238484562,0.00989284382233094,0.0311389787709258,0.000154215754165026
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23547.Cholesterol in Small LDL,41900,0.00857426867039986,0.00545363955936318,-0.00211486486595196,0.0192634022067517,0.115925558255637
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,41900,0.0226923849147046,0.0054529866853113,0.0120045310114945,0.0333802388179148,3.18208682260985e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23549.Free Cholesterol in Small LDL,41900,-0.0285610492463879,0.00544320766287959,-0.0392297362656319,-0.0178923622271439,1.56887013615873e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23550.Triglycerides in Small LDL,41900,0.112258743538042,0.00545863057407118,0.101559827612862,0.122957659463221,1.5329654698104e-92
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,41900,-0.0829069596946735,0.00629028938040545,-0.0952359268802682,-0.0705779925090788,2.01633367220274e-39
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23552.Total Lipids in Very Large HDL,41900,-0.0844576340611154,0.00631180149232718,-0.0968287649860766,-0.0720865031361541,1.43024132106896e-40
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23553.Phospholipids in Very Large HDL,41900,-0.0788959051065193,0.00628580988941651,-0.0912160924897756,-0.0665757177232629,6.23833922639334e-36
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23554.Cholesterol in Very Large HDL,41900,-0.102754509672225,0.00636501766620707,-0.115229944297991,-0.0902790750464592,4.48318741580553e-58
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,41900,-0.122124400561562,0.00637216708993878,-0.134613848057842,-0.109634953065282,8.82487552421334e-81
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,41900,-0.033985513163095,0.00624225699478605,-0.0462203368728756,-0.0217506894533143,5.28946406966801e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23557.Triglycerides in Very Large HDL,41900,0.0632688435421273,0.00526099332963115,0.0529572966160502,0.0735803904682043,3.85249690914923e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23558.Concentration of Large HDL Particles,41900,-0.185018488985471,0.00618212563948884,-0.197135455238869,-0.172901522732073,1.63483745372203e-190
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23559.Total Lipids in Large HDL,41900,-0.179363716762599,0.00614058028843026,-0.191399254127922,-0.167328179397275,7.57926008760202e-182
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23560.Phospholipids in Large HDL,41900,-0.172747378516868,0.00609285931794368,-0.184689382780038,-0.160805374253699,9.48977812024068e-172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23561.Cholesterol in Large HDL,41900,-0.191839460588186,0.0062095106156516,-0.204010101394864,-0.179668819781509,1.84469124196572e-202
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,41900,-0.199868794863034,0.00621242183584179,-0.212045141661284,-0.187692448064784,9.24056510180836e-219
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23563.Free Cholesterol in Large HDL,41900,-0.161408876257956,0.00620116689587782,-0.173563163373876,-0.149254589142035,1.00990894883966e-145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23564.Triglycerides in Large HDL,41900,0.00430158523620259,0.0055622831190135,-0.00660048967706386,0.0152036601494691,0.439329698881324
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23565.Concentration of Medium HDL Particles,41900,-0.177116149567728,0.00563620949249877,-0.188163120173026,-0.16606917896243,3.73152163465519e-209
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23566.Total Lipids in Medium HDL,41900,-0.161510586924513,0.005571837046983,-0.1724313875366,-0.150589786312426,3.36989278909606e-179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23567.Phospholipids in Medium HDL,41900,-0.140811987029434,0.00551564331566789,-0.151622647928143,-0.130001326130725,2.16493136319414e-140
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23568.Cholesterol in Medium HDL,41900,-0.198161353324151,0.00565312413201683,-0.209241476622904,-0.187081230025398,1.48961816872377e-257
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,41900,-0.201596290068205,0.00563513049428567,-0.212641145837005,-0.190551434299405,1.05851787056718e-267
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,41900,-0.177689957318584,0.00573361694088218,-0.188927846522713,-0.166452068114455,1.13673705439724e-203
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23571.Triglycerides in Medium HDL,41900,0.0561474625755021,0.00568971680729302,0.0449956176332078,0.0672993075177964,6.85047375386873e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23572.Concentration of Small HDL Particles,41900,-0.102563993918385,0.00539558935179805,-0.113139349047909,-0.0919886387888609,1.62655292979638e-79
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23573.Total Lipids in Small HDL,41900,-0.0835615996043072,0.00541574162205319,-0.0941764531835315,-0.072946746025083,3.00223620076655e-53
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23574.Phospholipids in Small HDL,41900,-0.0824616545939872,0.00538741597962864,-0.0930209899140594,-0.0719023192739151,1.93969003377674e-52
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23575.Cholesterol in Small HDL,41900,-0.11682155354702,0.0053446032600275,-0.127296975936673,-0.106346131157366,4.40047445198479e-104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,41900,-0.122282106034058,0.00536683659841994,-0.132801105766961,-0.111763106301155,9.23159926280117e-113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23577.Free Cholesterol in Small HDL,41900,-0.088055084137677,0.00537243659620896,-0.0985850598662465,-0.0775251084091075,8.66071002112205e-60
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23578.Triglycerides in Small HDL,41900,0.124012132228453,0.00606085411404849,0.112132858164917,0.135891406291988,1.2232476689814e-91
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,0.0147965750653731,0.00617219135902885,0.0026990800016765,0.0268940701290696,0.0165306457367782
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,-0.0751960304654874,0.00588339969297182,-0.0867274938637121,-0.0636645670672626,3.513085384512e-37
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,-0.056273648654333,0.0059826199364998,-0.0679995837298726,-0.0445477135787934,6.0020871892126e-21
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,-0.0932347729438253,0.00585932336426305,-0.104719046737781,-0.0817504991498697,1.79125686313458e-56
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41521,0.0576777905081039,0.00597526145956501,0.0459662780473565,0.0693893029688513,5.67571983360944e-22
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,41828,0.0741880142598274,0.00601489624420278,0.06239881762119,0.0859772108984649,9.21892499287404e-35
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,41828,-0.102648697216439,0.00604082089410928,-0.114488706168893,-0.0908086882639846,4.45804333276351e-64
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,41828,-0.110904114541624,0.00598976384002533,-0.122644051668074,-0.0991641774151745,1.38972211429635e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,41828,-0.0437161054754993,0.00611997724431461,-0.0557112608743559,-0.0317209500766426,9.59658179776698e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,41828,0.069466060000768,0.00605682467006603,0.0575946836474386,0.0813374363540974,2.62428905463147e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,41900,0.140857849602368,0.00620856326294911,0.128689065606988,0.153026633597748,7.76052188959836e-112
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,41900,-0.0437416743003385,0.00589384114162167,-0.055293602937917,-0.03218974566276,1.22745472098533e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,41900,-0.0727783433505971,0.00596349605581777,-0.0844667956199999,-0.0610898910811942,4.5027213246114e-34
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,41900,0.0430514054640269,0.00599279141078392,0.0313055342988905,0.0547972766291634,7.1374464298713e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,41900,-0.0202230898694027,0.00602738574205767,-0.0320367659238357,-0.00840941381496964,0.000795291989131472
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,41900,-0.0619422009383846,0.00576774932921307,-0.0732469896236422,-0.050637412253127,8.55983250843752e-27
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,41900,-0.107611888101393,0.00592070228303743,-0.119216464576146,-0.0960073116266392,6.14214011964914e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,41900,-0.11522960024526,0.00594845781227562,-0.12688857755732,-0.1035706229332,1.83548142889005e-82
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,41900,-0.0839483077892877,0.00581774583759353,-0.095351089630971,-0.0725455259476044,7.59785977633069e-47
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,41900,0.0981868441457174,0.00588293477419724,0.0866562919882908,0.109717396303144,6.58660374901653e-62
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,41900,-0.10669365344743,0.00576427431348558,-0.117991631101861,-0.095395675792998,1.53499059748736e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,41900,-0.0677955537236491,0.00560617180802138,-0.078783650467371,-0.0568074569799272,1.72307904791733e-33
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,41900,-0.0321664575482609,0.00555024158320779,-0.0430449310513481,-0.0212879840451736,6.9659680403469e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,41900,-0.113052349442516,0.00580596890125838,-0.124432048488982,-0.101672650396049,2.7418802598329e-83
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,41900,0.080328249795658,0.00565039329989746,0.069253478927859,0.091403020663457,1.56185259718874e-45
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,41900,0.15581823851936,0.00536271577388795,0.14530731560254,0.166329161436181,5.1294971862227e-180
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,41900,-0.124240317876319,0.00572847925488652,-0.135468137215896,-0.113012498536741,1.57000361470961e-102
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,41900,-0.134873014333432,0.00579355750318271,-0.14622838703967,-0.123517641627194,1.56417341748242e-117
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,41900,-0.0294871506162817,0.00513303101050714,-0.0395478913968757,-0.0194264098356877,9.41624979626799e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,41900,0.0993795633850806,0.00568967411108095,0.088227802127362,0.110531324642799,1.45710726475801e-67
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,41900,0.0878978564087146,0.00535020786161782,0.0774114489999437,0.0983842638174855,4.63622410330507e-60
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,41900,-0.135024910865307,0.00554886214180156,-0.145900680663238,-0.124149141067376,5.29997473942446e-128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,41900,-0.131077695865477,0.00547518399599891,-0.141809056497635,-0.120346335233319,4.81461391434925e-124
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,41900,-0.0536787909352265,0.00517424734390843,-0.0638203157292871,-0.043537266141166,4.05015879565703e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,41900,0.128368819043661,0.0055966141831705,0.117399455244647,0.139338182842675,3.23174043614325e-114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,41900,-0.00635713925537338,0.0055389867005549,-0.017213553188461,0.00449927467771422,0.251109778111039
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,41900,-0.121604904029329,0.0055424325362304,-0.132468071800341,-0.110741736258318,7.60885094005538e-105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,41900,-0.0386605772155997,0.00539255858072321,-0.0492299920338172,-0.0280911623973822,7.93929863648941e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,41900,-0.143175403283598,0.00591923997571782,-0.154777113636005,-0.131573692931191,1.57207395217596e-126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,41900,0.119086389866291,0.00545766049087695,0.108389375304172,0.129783404428409,9.78170014254658e-104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,41900,-0.0322188184882551,0.00569065779370591,-0.0433725077639187,-0.0210651292125915,1.5297731108961e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,41900,-0.0839987857352375,0.00557438143814586,-0.0949245733540034,-0.0730729981164716,6.83899075764415e-51
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,41900,0.0653387839363261,0.0056626587861347,0.0542399727155021,0.0764375951571502,1.1802774001832e-30
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,41900,-0.142738100067686,0.00570785711319496,-0.153925500009548,-0.131550700125824,6.49736888045242e-135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,41900,0.102919566156937,0.00546565378826032,0.0922068847319471,0.113632247581928,4.40989756878678e-78
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,41900,-0.00886455160924924,0.00565733215414998,-0.0199529226313832,0.00222381941288471,0.117158640721636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,41900,-0.093514853890415,0.00545307412604292,-0.104202879177459,-0.0828268286033709,3.20790268071029e-65
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,41900,0.0211131898356984,0.00560690329024154,0.010123659386825,0.0321027202845718,0.000166884862311486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,41900,-0.115745249575393,0.00545934238720041,-0.126445560654306,-0.105044938496481,3.87426525111889e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,41900,0.117655019054358,0.00555666277025376,0.106763960024661,0.128546078084056,6.83449930359462e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,41888,-0.0542410422165108,0.00601311906597548,-0.0660267555858227,-0.0424553288471988,2.12703412954558e-19
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,41888,-0.0166162339273392,0.00523132888761073,-0.0268696385470562,-0.00636282930762219,0.0014951114080249
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,41888,-0.105407916793637,0.00478331272066766,-0.114783209726145,-0.0960326238611281,9.945791660256e-106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,41888,0.135273268253644,0.00613120709274251,0.123256102351869,0.147290434155419,5.65610766845546e-106
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,41888,0.116326537502899,0.00579920403749454,0.10496009758941,0.127692977416389,3.38201711920073e-88
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,41900,0.0797782677837728,0.00550636310349745,0.0689857961009178,0.0905707394666278,3.28238485462267e-47
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,41900,-0.137106933038717,0.00574326969538932,-0.14836374164168,-0.125850124435754,2.27862751939564e-123
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,41900,-0.139235063846739,0.0055105276884275,-0.150035698116057,-0.128434429577421,1.26146093162382e-137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,41900,-0.0225762148115603,0.00561626713407142,-0.0335840983943403,-0.0115683312287804,5.8571204828136e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,41900,0.143808371133008,0.00549600487167013,0.133036201584534,0.154580540681481,3.33375103356722e-147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,41900,0.202987780015767,0.00573983787811297,0.191737697774666,0.214237862256869,6.53591583351636e-262
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,41900,-0.194967217637148,0.00575546299008273,-0.206247925097711,-0.183686510176586,2.37858355675556e-241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,41900,-0.163321654549051,0.00552128922919189,-0.174143381438267,-0.152499927659835,2.69092261509472e-186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,41900,-0.180836033441104,0.00605348179279613,-0.192700857754984,-0.168971209127223,7.62723903321713e-190
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,41900,0.171931340699003,0.00572599641025385,0.160708387734905,0.1831542936631,1.02618641150278e-191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,41900,-0.0127259157152951,0.00550489682961313,-0.0235155135013368,-0.00193631792925332,0.0208069627675523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,41900,-0.099418785467915,0.00537661036271323,-0.109956941778833,-0.0888806291569971,2.14466381470496e-75
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,41900,-0.0913094262355472,0.00530987087039019,-0.101716773141512,-0.0809020793295825,1.44889886846058e-65
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,41900,-0.0306134105076405,0.00582278915552455,-0.0420260772524687,-0.0192007437628124,1.48274642803067e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,41900,0.195304094877417,0.00592456608219714,0.183691945356311,0.206916244398524,3.73319820744178e-229
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,51531,-0.00177325100394147,0.00471123583049609,-0.0110072732317138,0.00746077122383088,0.706632204984405
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,51531,-0.00102369212012527,0.00457752744041821,-0.00999564590334495,0.00794826166309442,0.823043868374068
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50012,-0.000265157058743215,0.00439122576533329,-0.00887195955879647,0.00834164544131004,0.95185085803221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50012,0.00519045044315589,0.00478371941367286,-0.00418563960764292,0.0145665404939547,0.277923235215539
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50012,-0.00547628982255092,0.00473965746268024,-0.0147660184494042,0.00381343880430235,0.247931817956622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50012,-0.00237658276695919,0.00435950436802477,-0.0109212113282877,0.00616804579436936,0.585656198711384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24009.Traffic intensity on the nearest road,51531,-0.0767144840739936,0.0438512024965582,-0.162662840967248,0.00923387281926044,0.0802305891816568
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24010.Inverse distance to the nearest road,51531,0.00350103339374865,0.00411864557896616,-0.00457151194102502,0.0115735787285223,0.395309035862098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24011.Traffic intensity on the nearest major road,51531,0.00559240381261811,0.00410993568361785,-0.00246307012727287,0.0136478777525091,0.173620785818554
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24012.Inverse distance to the nearest major road,51531,-0.0034315266879831,0.00416225018236888,-0.0115895370454261,0.0047264836694599,0.409698013355148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24013.Total traffic load on major roads,51531,-0.0272893010947562,0.0301744746344352,-0.0864312713782491,0.0318526691887368,0.365801513447788
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24015.Sum of road length of major roads within 100m,51531,-0.0308999768981805,0.0293309968614595,-0.0883887307466411,0.0265887769502802,0.292126560459223
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,51531,-0.00639991180533399,0.0047295331557847,-0.015669796790672,0.00286997318000403,0.176011328863821
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,51531,-0.00652497992500839,0.00472936368321912,-0.0157945327441179,0.00274457289410109,0.16770050650518
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,51531,-0.00556326158209246,0.00467388326601638,-0.0147240727834846,0.00359754961929964,0.233946007224304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,51496,0.00631459845638926,0.0045721010704235,-0.00264671964164081,0.0152759165544193,0.167257010176354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24020.Average daytime sound level of noise pollution,51531,0.00185800048327628,0.00411699692065032,-0.00621131348119836,0.00992731444775091,0.651777652369007
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24021.Average evening sound level of noise pollution,51531,0.00191627475103387,0.00411698238781304,-0.0061530107290797,0.00998556023114743,0.641609255847393
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24022.Average night-time sound level of noise pollution,51531,0.00184409363901202,0.00411711260331444,-0.00622544706348429,0.00991363434150832,0.654222779923933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24023.Average 16-hour sound level of noise pollution,51531,0.00186371804545735,0.00411712358540946,-0.00620584418194519,0.0099332802728599,0.650787219403028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24024.Average 24-hour sound level of noise pollution,51531,0.00189392019409857,0.00411713674754403,-0.00617566783108772,0.00996350821928486,0.645514080813493
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2405.Number of children fathered,51525,0.0336174276064672,0.0227410453523591,-0.0109550212841566,0.0781898764970911,0.13934899863809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49071,-0.00264837613654461,0.00485343291341857,-0.012161104646845,0.00686435237375579,0.585298261551561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49071,0.00651292430011951,0.00436274271886794,-0.00203805142886164,0.0150639000291007,0.135491636826986
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24502.Water percentage, buffer 1000m",49071,-0.00855273241468538,0.00440252883491122,-0.0171816889311114,7.62241017406139e-05,0.0520677671259454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49071,1.76784078187075e-05,0.00456444726586777,-0.00892863823328212,0.00896399504891953,0.996909785498298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49071,0.00303609126526658,0.00440608603024784,-0.00559983735401919,0.0116720198845524,0.49078851787215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24505.Water percentage, buffer 300m",49071,-0.0016334163974448,0.0044230851241333,-0.0103026632407461,0.00703583044585647,0.711912821363702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",51615,-0.00598001273283015,0.00467515243173802,-0.0151433114990367,0.00318328603337636,0.200872837486762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,"X24507.Natural environment percentage, buffer 300m",51615,0.000774254833684517,0.00437877608698829,-0.00780814629681253,0.00935665596418157,0.859651398253944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X24508.Distance (Euclidean) to coast,51615,0.00435537369728945,0.00413412241708404,-0.00374750624019527,0.0124582536347742,0.292114563155751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2867.Age started smoking in former smokers,35377,0.00188864244168665,0.00755944029554667,-0.0129278605375848,0.0167051454209581,0.802719488244849
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",36883,-0.0172897765943417,0.044879185105008,-0.105252979400157,0.070673426211474,0.70006093257891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,36882,-0.0645773269141443,0.0519267336656447,-0.166353724898808,0.0371990710705192,0.213673224950138
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,36881,-0.00642972099754345,0.0480779616980038,-0.100662525925631,0.0878030839305439,0.893615135041619
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",36871,-0.00321045199203157,0.0480903041092925,-0.0974674480462449,0.0910465440621818,0.94677532047564
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28739.Difficulty with standing for long periods,36887,0.125826538539081,0.0411593849532755,0.0451541440306614,0.206498933047501,0.00224234996514881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28740.Difficulty with taking care of household responsibilities,36904,0.0488834001096304,0.0478622490286323,-0.0449266079864889,0.14269340820575,0.307125414335066
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28741.Difficulty learning a new task,36859,0.0275280333089075,0.0560593441709898,-0.0823482812662325,0.137404347884048,0.623402971215271
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28742.Difficulty with joining in community activities,36443,-0.0518403479381915,0.0523964286993145,-0.154537348188848,0.0508566523124648,0.322504342208385
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28743.Difficulty with being emotionally affected by health problems,36856,0.0257080120840362,0.0455236200454617,-0.0635182832050687,0.114934307373141,0.57228087115629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,36910,0.0239803142074623,0.0606283322251579,-0.0948512169538473,0.142811845368772,0.692462065008403
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34788,0.0143743964302052,0.0424507216028785,-0.0688290179114366,0.0975778107718469,0.734912241868765
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2897.Age stopped smoking,35375,0.0372729734053616,0.00799551973573319,0.0216017547233246,0.0529441920873986,3.19561845322486e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,35961,-0.00852772759093559,0.0161087274427918,-0.0401008333788075,0.0230453781969363,0.596553981908688
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,35961,0.0109181258202505,0.018215063407445,-0.0247833984583417,0.0466196500988426,0.548924009316057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,35961,0.0803734475305965,0.060129490975282,-0.0374803547809563,0.198227249842149,0.181370816259239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,35961,-0.0647030319820042,0.0598372156269862,-0.181983974610897,0.0525779106468887,0.27959130251432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,35961,0.0921815956066322,0.0734158440250446,-0.0517134586824552,0.23607664989572,0.209297615683186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,35961,0.055460606942996,0.0664565871446226,-0.0747943038604644,0.185715517746456,0.404004460243897
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,35961,0.0023207797485435,0.027396499243315,-0.0513763587683539,0.0560179182654409,0.932493602312295
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,35961,-0.0288378579503521,0.0513254816432151,-0.129435801971054,0.0717600860703495,0.574226884576635
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29002.Recent lack of interest or pleasure in doing things,35917,0.0342128429303766,0.0481966312600724,-0.0602525543393653,0.128678240200118,0.477813812511369
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29003.Recent feelings of depression,35918,0.0142667378944808,0.0481171597767026,-0.0800428952678564,0.108576371056818,0.766856683052097
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",35922,0.0723610412090862,0.0375336540162423,-0.00120492066274877,0.145927003080921,0.0539065044447494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29005.Recent feelings of tiredness or low energy,35923,0.084016535623605,0.0371855126541115,0.0111329308215465,0.156900140425664,0.0238884809790537
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29006.Recent poor appetite or overeating,35929,-0.0258552630156702,0.0590313501688822,-0.141556709346679,0.0898461833153389,0.661404946229659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29007.Recent feelings of inadequacy,35906,0.01081211129761,0.0523772314928733,-0.0918472624284215,0.113471485023642,0.836462590976636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29008.Recent trouble concentrating on things,35924,0.0315771413481503,0.0499940381109442,-0.0664111733493004,0.129565456045601,0.527656148517118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29009.Recent changes in speed or amount of moving or speaking,35923,0.0440699389228512,0.085466281747856,-0.123443973302947,0.211583851148649,0.60612057673239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29010.Recent thoughts of suicide or self-harm,35904,0.0886325358903755,0.0909619771860952,-0.0896529393943712,0.266918011175122,0.32989469214293
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#0.Substances taken for depression_None of options listed,35874,0.0319244631486508,0.0310876271572606,-0.02900728607958,0.0928562123768815,0.304492933144196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35874,-0.0453403327962157,0.0570562315653062,-0.157170546664216,0.0664898810717845,0.426836948386733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35874,-0.032800106036932,0.0342925181930718,-0.100013441695353,0.0344132296214888,0.33886159676643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35874,0.178009614644624,0.101820470960294,-0.0215585084375517,0.377577737726799,0.0804595731408145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35874,-0.0789847275373381,0.0678777521865139,-0.212025121822905,0.0540556667482291,0.244611327065409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35874,0.125486294965668,0.0769936325778238,-0.0254212248868666,0.276393814818203,0.103181381161727
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35874,0.0114769981845829,0.0814880462305521,-0.148239572427299,0.171193568796465,0.887998092639319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35874,0.012205905430884,0.095565934284475,-0.175103325766687,0.199515136628455,0.898372235116013
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35874,-0.0267037838267974,0.0669679951505234,-0.157961054321823,0.104553486668228,0.690085872321246
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35874,-0.0052757118717437,0.0291749365798907,-0.0624585875683295,0.0519071638248421,0.856505834855291
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35874,-0.0580105451000774,0.0469805335786906,-0.150092390914311,0.0340713007141561,0.216952896677166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35874,0.0533885536956664,0.0742173338669153,-0.0920774206834876,0.19885452807482,0.471945794414274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35874,0.0669794949559554,0.0904475036128644,-0.110297612125259,0.24425660203717,0.458999650407529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35874,0.0369086722898645,0.0544322235526471,-0.0697784858733238,0.143595830453053,0.497751040360871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35874,0.0292203367168477,0.0836520857385681,-0.134737751330746,0.193178424764441,0.726868258803149
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35874,0.111586316164097,0.0822958804464863,-0.049713609511016,0.27288624183921,0.175167928458132
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35874,0.00483677762922189,0.0472079761019759,-0.0876908555306508,0.0973644107890946,0.918396934170679
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35874,0.00513506696709198,0.0448078151626609,-0.0826882507517234,0.0929583846859074,0.908763726766135
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35874,0.0819107190014562,0.0663206378490408,-0.0480777311826638,0.211899169185576,0.216843846145675
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29058.Recent feelings or nervousness or anxiety,35807,0.0157776660350099,0.0465763679593541,-0.0755120151653242,0.107067347235344,0.734809213535585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29059.Recent inability to stop or control worrying,35813,0.0125697592594795,0.0493966984378862,-0.0842477696787774,0.109387288197736,0.799143152225801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29060.Recent worrying too much about different things,35811,0.010197788571684,0.0440453126338493,-0.0761310241906605,0.0965266013340286,0.816910052694498
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29061.Recent trouble relaxing,35808,0.0375124378322176,0.046785104816582,-0.0541863676082831,0.129211243272718,0.422693356781841
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29062.Recent restlessness,35816,0.0255468851253329,0.0642411353233768,-0.100365740108486,0.151459510359151,0.690883925448559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29063.Recent easy annoyance or irritability,35806,0.0292711763486637,0.0449116188914542,-0.0587555966785865,0.117297949375914,0.514582840228263
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29064.Recent feelings of foreboding,35808,0.0818547890338924,0.0553038728330607,-0.0265408017189065,0.190250379786691,0.138892560966445
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35874,-0.0425529006359354,0.03659627336089,-0.11428159642328,0.029175795151409,0.244962619718245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35874,-0.0711222893434909,0.055625365262664,-0.180148005258312,0.0379034265713305,0.201080659509721
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35874,-0.0928399205860265,0.0764985166607314,-0.24277701324106,0.057097172069007,0.22493331529091
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35874,0.0292498217620326,0.0763974019558094,-0.120489086071354,0.178988729595419,0.701831725635347
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#2.Symptoms of panic attack_Sweating,35874,0.0453990130852049,0.0474961662373677,-0.0476934727400359,0.138491498910446,0.339181888064023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35874,0.0839746855063873,0.0591812504681435,-0.0320205654111739,0.199969936423949,0.15595914853868
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35874,0.00338551402534374,0.0570331901698485,-0.108399538707559,0.115170566758247,0.952666669702937
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35874,0.0486010036723352,0.0561241354583838,-0.061402301826097,0.158604309170767,0.38654312697838
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35874,0.094567664483542,0.0708446140467873,-0.0442877790481611,0.233423108015245,0.181963842359971
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29076.Felt loved as a child,35777,-0.0249570372070781,0.0377245655953937,-0.0988971857740497,0.0489831113598935,0.50827494555469
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29077.Physically abused by family as a child,35788,0.0400126771118442,0.0483210020636618,-0.054696486932933,0.134721841156621,0.407664163293351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29078.Felt hated by family member as a child,35782,0.0995335692109806,0.054004777734641,-0.00631579514891586,0.205382933570877,0.0653627379145526
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29079.Sexually molested as a child,35764,0.278761913056936,0.0758300123372919,0.130135088875844,0.427388737238028,0.000238519749036656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29080.Someone to take to doctor when needed as a child,35774,-0.0999859518168406,0.0570765402048976,-0.21185597061844,0.0118840669847587,0.079853151969915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,35786,-0.0757032825130117,0.0847495584953165,-0.241812417163832,0.0904058521378086,0.371748553611496
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35763,-0.104308658568652,0.0719951709758577,-0.245419193681333,0.036801876544029,0.147429250451147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29083.Physical violence by partner or ex-partner as an adult,35798,0.0356235002343801,0.0793563841349444,-0.119915012670111,0.191162013138871,0.653513499352527
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,35791,0.112042703348372,0.236188763703519,-0.350887273510525,0.574972680207269,0.635244935549239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,35784,0.00387065106607253,0.152822047206849,-0.295660561459351,0.303401863591496,0.979794178260414
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29086.Experienced a violent or sexual assault,35803,0.0767851339966104,0.0840097283017129,-0.087873933474747,0.241444201467968,0.360745927536489
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29087.Experienced a life-threatening injury or illness,35794,0.0443561736657635,0.0432387772040297,-0.0403918296541348,0.129104176985662,0.305000343653657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29088.Experienced a marital separation or divorce,35793,-0.0495456117612445,0.0434553247091014,-0.134718048191083,0.0356268246685941,0.254261558561528
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29089.Experienced the death of a spouse or partner,35805,-0.00282448000925077,0.0661761712525497,-0.132529775664248,0.126880815645747,0.965956829611172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,35798,0.0191267397116996,0.0526630920125567,-0.0840929206329115,0.122346400056311,0.716473179426379
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29091.Frequency of drinking alcohol,35790,-0.303532537246492,0.0349631734751523,-0.37206035725779,-0.235004717235193,4.77761019970293e-18
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35203,-0.277459919944019,0.0378667879033229,-0.351678824234532,-0.203241015653506,2.62900486344501e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35222,-0.283261762524299,0.0380348796820736,-0.357810126701163,-0.208713398347435,1.07284156372092e-13
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29104.Ever used cannabis,35784,-0.111889933321541,0.047546491030829,-0.205081055741966,-0.0186988109011166,0.0186357176450974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29108.Ever thought that life not worth living,35759,0.0443268674647996,0.0466004714658603,-0.0470100566082867,0.135663791537886,0.34152953992215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29109.Ever contemplated self-harm,35768,0.115562316477377,0.0638979300338277,-0.00967762638892489,0.24080225934368,0.0705635282098222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29111.Ever self-harmed,35777,0.161522617122533,0.110648740592197,-0.0553489144381739,0.378394148683239,0.144394821483009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35778,-0.00406797198405311,0.0708515253997546,-0.142936961767572,0.134801017799466,0.954215856918877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36436,0.0672878466581836,0.0750447271815569,-0.079799818617668,0.214375511934035,0.369940422958015
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36436,-0.0242590092450491,0.0576161167376777,-0.137186598050897,0.0886685795607993,0.673733372308086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36436,0.0445173196701028,0.073067387877121,-0.0986947605690544,0.18772939990926,0.542367213214607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36436,0.0900036259616301,0.118234381249597,-0.141735761287579,0.32174301321084,0.446542266601476
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35768,-0.124090355401957,0.0409546460918002,-0.204361461741885,-0.0438192490620285,0.00245469908622674
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X29153.Pain or discomfort today,35781,0.0811682212072076,0.0368814571287992,0.00888056523476104,0.153455877179654,0.0277828540425067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29154.Anxiety or depression today,35781,0.0508625956354588,0.0487130498343702,-0.0446149820399069,0.146340173310824,0.296461939028886
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29166.Frequency of confiding in someone close,35611,-0.0830110423165797,0.0367347251915993,-0.155011103692114,-0.011010980941045,0.023867777929903
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35764,0.00494800839670348,0.0152416886490778,-0.024925701355489,0.034821718148896,0.745465680748082
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35764,-0.0239853048188305,0.0157953233360859,-0.0549441385575589,0.00697352891989796,0.128930830568286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35764,-0.0428850238000773,0.0167267794659287,-0.0756695115532976,-0.010100536046857,0.0103719177316329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35764,0.0838275692916985,0.0232590651953624,0.0382398015087883,0.129415337074609,0.000315385118978116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35764,0.0125255556503883,0.046284257704925,-0.0781915894512648,0.103242700752041,0.786689282602853
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35764,0.0130870849332767,0.0169838084670286,-0.0202011796620994,0.0463753495286527,0.440991740323426
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35759,-0.00807714568653869,0.0178805339254,-0.0431229921803228,0.0269687008072454,0.651478312337686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35759,-0.013984717149603,0.0282815662840475,-0.0694165870663361,0.04144715276713,0.620981195967866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35759,-0.0268996299057844,0.0320349529029936,-0.089688137595652,0.0358888777840831,0.401106755482494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35759,0.0863781242097916,0.0394469380807303,0.00906212557156022,0.163694122848023,0.0285760205745963
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35759,0.0734713157331272,0.063956578131282,-0.0518835774041856,0.19882620887044,0.250689745277959
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35759,0.0152141202870011,0.0259669509656649,-0.0356811036057021,0.0661093441797044,0.5579590207269
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29171.Frequency of feeling 'in tune' with people,35588,-0.00351815586914304,0.0448144281568749,-0.0913544350566178,0.0843181233183317,0.93742861557571
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29172.Freuency of feeling that lacks companionship,35721,0.047849927066191,0.0420420246427524,-0.0345524412336037,0.130252295365986,0.255098167016045
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29173.Frequency of feeling left out,35693,0.131952341827116,0.043200798376177,0.0472787770098093,0.216625906644423,0.002263512248009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29174.Frequency of feeling isolated from others,35725,0.0745998085511626,0.0444025566407267,-0.0124292024646618,0.161628819566987,0.0929857660852769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29175.Tendency to bounce back quickly after hard times,35774,-0.039780853944018,0.0362820983746839,-0.110893766758398,0.0313320588703624,0.272926582090086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29176.Ability to make it through stressful events,35774,0.0249938729322536,0.0352330832335969,-0.0440629702055962,0.0940507160701035,0.478107738071667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29177.Quick recovery from stressful events,35774,-0.0136072361651618,0.0362125419906728,-0.0845838184668805,0.057369346136557,0.707106208541193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29178.Hard to snap back when something bad happens,35774,0.0171390505794972,0.0357019275707498,-0.0528367274591724,0.0871148286181667,0.631199706049523
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29179.Comes through difficult times with little trouble,35774,-0.0279883868929241,0.0359663002476592,-0.0984823353783362,0.0425055615924881,0.436486427164286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29180.Tendency to take a long time to get over setbacks,35774,-0.00315202747609361,0.0357153668357877,-0.0731541464742376,0.0668500915220503,0.929677185591342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29181.General happiness,35736,0.0274987963766869,0.0368838664145099,-0.0447935817957525,0.0997911745491263,0.455963378423533
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,X29182.Belief that own life is meaningful,35637,0.0258229685459052,0.0371500535133285,-0.0469911363402186,0.0986370734320291,0.48701616304917
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34715,0.0660359997439817,0.0381811131013397,-0.00879898193464405,0.140870981422608,0.0837618535973294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2946.Father's age,33428,-0.0222194936315866,0.0133376523700814,-0.0483612922769461,0.00392230501377285,0.0957937476540104
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X2966.Age high blood pressure diagnosed,35379,-0.00206895363852187,0.0102429406714493,-0.0221451173545625,0.0180072100775187,0.839931972660924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30000.White blood cell (leukocyte) count,51172,0.176770906263332,0.0042244780094665,0.168490929364778,0.185050883161886,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51173,0.00585612420117095,0.0047195667987688,-0.0033942267244159,0.0151064751267578,0.214685825776731
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30020.Haemoglobin concentration,51173,-0.0297641614201017,0.00495939365007508,-0.0394845729742489,-0.0200437498659546,1.98396809752552e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30030.Haematocrit percentage,51173,-0.0193015648793346,0.00487269336879615,-0.028852043882175,-0.0097510858764941,7.48125291703269e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30040.Mean corpuscular volume,51173,-0.0371387832892083,0.00433631660590736,-0.0456379638367867,-0.0286396027416298,1.15289515841831e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51173,-0.045377558630526,0.00435131398597304,-0.0539061340430331,-0.0368489832180188,2.09959681611499e-25
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51173,-0.0233793676228015,0.00423715720901665,-0.0316841957524741,-0.0150745394931288,3.47234355088308e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51173,0.01746448717306,0.00443765251307758,0.00876668824742796,0.0261622860986921,8.32641287119172e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30080.Platelet count,51173,0.167085407669203,0.00419461001595095,0.158863972037939,0.175306843300467,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30090.Platelet crit,51173,0.16945604798269,0.00427009935924228,0.161086653238576,0.177825442726805,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51173,-0.0421267631106049,0.00409950413048807,-0.0501617912063615,-0.0340917350148483,1.02416596324523e-24
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30110.Platelet distribution width,51173,-0.0241259007423604,0.00421551867893462,-0.0323883173530723,-0.0158634841316485,1.05912747493824e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30120.Lymphocyte count,51135,0.187174367397708,0.00407374526316619,0.179189826681902,0.195158908113514,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30130.Monocyte count,51135,0.101122420434407,0.00422184612722819,0.0928476020250396,0.109397238843774,3.21957114645634e-125
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30140.Neutrophill count,51135,0.109472313685067,0.00427322100081575,0.101096800523468,0.117847826846666,1.05315022680842e-142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30150.Eosinophill count,51135,0.0862964032561229,0.00408718160566752,0.0782855273090145,0.0943072792032312,5.2728062487192e-98
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30160.Basophill count,51135,0.330471512297015,0.0228195141738073,0.285745264516353,0.375197760077677,2.57017548158884e-47
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30170.Nucleated red blood cell count,51135,0.391713498696553,0.0984926853180154,0.198667835473243,0.584759161919864,6.99839359755672e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30180.Lymphocyte percentage,51136,0.0606638097777672,0.00419974307391189,0.0524323133528999,0.0688953062026346,4.39864326175924e-47
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30190.Monocyte percentage,51136,-0.0233990694477392,0.0042274263634755,-0.0316848251201512,-0.0151133137753272,3.14581573047266e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30200.Neutrophill percentage,51136,-0.0518092071985772,0.00414913925432766,-0.0599415201370594,-0.043676894260095,1.15754531408577e-35
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30210.Eosinophill percentage,51136,0.0329585858226366,0.00408320460649896,0.0249555047938986,0.0409616668513746,7.27396473188406e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30220.Basophill percentage,51136,0.000319905114935663,0.00428070024764547,-0.00807026737044946,0.00871007760032078,0.940428642549295
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30230.Nucleated red blood cell percentage,51134,0.391485991503148,0.0987890094983056,0.197859532886469,0.585112450119827,7.42885900477102e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30240.Reticulocyte percentage,50794,0.0346960961088769,0.00451246074469092,0.0258516730492827,0.0435405191684711,1.54494562969859e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30250.Reticulocyte count,50794,0.0350979375388461,0.00455088178686595,0.0261782092365889,0.0440176658411034,1.28717833406916e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30260.Mean reticulocyte volume,50794,-0.026556774441244,0.00426783709305588,-0.0349217351436335,-0.0181918137388545,4.97929927514834e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30270.Mean sphered cell volume,50794,-0.0359021527768633,0.00429650940252714,-0.0443233112058165,-0.0274809943479101,6.85723349965057e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30280.Immature reticulocyte fraction,50794,0.0298277211762182,0.00443618116449274,0.0211328060938125,0.038522636258624,1.81422553255948e-11
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30290.High light scatter reticulocyte percentage,50794,0.0389291901590982,0.00456963293436175,0.0299727096077492,0.0478856707104473,1.70872148419456e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30300.High light scatter reticulocyte count,50794,0.0389882040557289,0.00458648629426394,0.0299986909189716,0.0479777171924863,2.00217989638116e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30500.Microalbumin in urine,36881,0.023197674322475,0.00692184910402594,0.00963085007858416,0.0367644985663659,0.000807728034924774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51229,0.0174587139542138,0.004605524805483,0.00843188533546711,0.0264855425729605,0.000150540482769922
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30520.Potassium in urine,51183,-0.0107434423755053,0.00430065805007982,-0.0191727321536618,-0.0023141525973489,0.0124934083375707
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30530.Sodium in urine,51195,-0.0018853083991226,0.0044507858897362,-0.0106088487430055,0.00683823194476035,0.671868880831852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30600.Albumin,49065,-0.0624672547690969,0.00454687595913248,-0.0713791316489966,-0.0535553778891972,9.24297912318025e-43
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30610.Alkaline phosphatase,50753,0.0670480305463932,0.00446151018762461,0.0583034705786489,0.0757925905141374,8.55574513321068e-51
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30620.Alanine aminotransferase,50739,0.0136014967936925,0.00484930372828446,0.004096861486255,0.0231061321011301,0.00503862157177979
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30630.Apolipoprotein A,49002,-0.224724868886576,0.00468099487991819,-0.233899618851215,-0.215550118921936,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30640.Apolipoprotein B,50594,0.0297916195328692,0.00420788636025589,0.0215441622667676,0.0380390767989707,1.485468811584e-12
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30650.Aspartate aminotransferase,50676,-0.0183597833708157,0.00447198877115785,-0.0271248813622851,-0.00959468537934635,4.04878984629383e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30660.Direct bilirubin,49219,-0.0677164828814075,0.00451405982884041,-0.0765640401459347,-0.0588689256168803,1.33292551121634e-50
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30670.Urea,50736,0.0147428390994739,0.00438898734934434,0.00614042389475902,0.0233452543041888,0.000783421469530682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30680.Calcium,49056,0.00507164630693784,0.00452256850774053,-0.00379258796823359,0.0139358805821093,0.262127226698441
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30690.Cholesterol,50757,-0.0257681873163677,0.00423778432333858,-0.0340742445901113,-0.0174621300426241,1.21708040542338e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30700.Creatinine,50745,0.0223955498289333,0.00547097946482181,0.0116724300778826,0.0331186695799841,4.26384411315625e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30710.C-reactive protein,50676,0.0907635957101804,0.00465409733518966,0.0816415649332087,0.0998856264871521,5.39129843804989e-84
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30720.Cystatin C,50760,0.0986605503450249,0.00502547262699891,0.088810623996107,0.108510476693943,4.34892247050432e-85
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30730.Gamma glutamyltransferase,50740,0.0091415095417936,0.00510309541271913,-0.000860557467135901,0.0191435765507231,0.0732482999412771
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30740.Glucose,49033,-0.0120493604926012,0.00430397793868344,-0.0204851572524208,-0.00361356373278167,0.00512160226076105
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),50644,0.0758569372071858,0.00428641654035092,0.067455560788098,0.0842583136262736,1.33934958258316e-69
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30760.HDL cholesterol,49042,-0.241654138233636,0.00482354371339333,-0.251108283911887,-0.232199992555385,0
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30770.IGF-1,50650,-0.00468735352475648,0.00449348193897371,-0.0134945781251449,0.00411987107563199,0.29689254643196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30780.LDL direct,50705,0.00511452980638775,0.00423184206231362,-0.00317988063574694,0.0134089402485224,0.226836252169685
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30790.Lipoprotein A,46265,-0.00701949538262752,0.00461501602002391,-0.0160649267818744,0.00202593601661934,0.128274689756573
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30810.Phosphate,49002,0.04860867531606,0.00440359674480985,0.0399776256962327,0.0572397249358873,2.99865984041746e-28
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30830.SHBG,48909,-0.057931767924431,0.00585530007433508,-0.0694081560701278,-0.0464553797787343,4.98831753953176e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30840.Total bilirubin,50662,-0.0832147159451795,0.00458190142739633,-0.0921952427428763,-0.0742341891474827,3.54890825558521e-73
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30850.Testosterone,50529,-0.0608005095695597,0.00724238651129359,-0.0749955871316951,-0.0466054320074243,4.93373121171757e-17
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30860.Total protein,49032,0.00769140303239089,0.00447747454387332,-0.00108444707360082,0.0164672531383826,0.0858483649685938
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30870.Triglycerides,50730,0.139102848715138,0.0043386162391868,0.130599160886332,0.147606536543944,1.65646558814289e-220
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30880.Urate,50724,0.0225951028219983,0.00529489955559479,0.0122170996930325,0.0329731059509641,1.98645634153626e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Blood and urine assays,X30890.Vitamin D,50096,-0.0253788640088272,0.00476573222365727,-0.0347196991671955,-0.016038028850459,1.0180952000738e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3137.Number of measurements made,49482,-0.0220655262917608,0.026564081190189,-0.0741311254245313,0.0300000728410097,0.406179340270146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3143.Ankle spacing width,41775,-0.0193027029701342,0.00768638624107221,-0.0343680200026358,-0.00423738593763269,0.0120411369722333
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",41774,-0.0139358174689705,0.00559774906371113,-0.0249074056338443,-0.00296422930409668,0.0128031083913606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3146.Speed of sound through heel,41775,-0.0181780059563619,0.00540298844474166,-0.0287678633080556,-0.00758814860466826,0.000769192090856641
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",41775,-0.0171919333711989,0.00545538442198732,-0.027884486838294,-0.00649937990410374,0.00162870590558131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X3148.Heel bone mineral density (BMD),41756,-0.0176395092656092,0.00548577907624856,-0.0283916362550564,-0.00688738227616201,0.00130533173097511
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X3526.Mother's age at death,42489,-0.0139446031854659,0.00551034355137328,-0.0247448765461576,-0.00314432982477431,0.01139695812591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32877,0.013942649958337,0.00993931565883759,-0.00553840873298464,0.0334237086496587,0.160755734474363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4100.Ankle spacing width (left),36049,-0.0170976691332228,0.0102607721256299,-0.0372087824994574,0.00301344423301174,0.0956929164882353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36047,0.00526149322898983,0.00744825061030583,-0.00933707796720961,0.0198600644251893,0.479957430846227
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4103.Speed of sound through heel (left),36049,0.000383531150910503,0.00712644835410911,-0.0135843076231434,0.0143513699249644,0.957081616796532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36049,0.00193026537517907,0.00722688729322864,-0.0122344337195491,0.0160949644699072,0.789403420366934
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4105.Heel bone mineral density (BMD) (left),36039,0.00183018184102355,0.00726484578880257,-0.0124089159050295,0.0160692795870766,0.801107530570611
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36049,0.00191969076862277,0.0072273511932114,-0.0122459175700716,0.0160852991073171,0.790543308362813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4119.Ankle spacing width (right),36037,-0.00725617214085685,0.0100646110453739,-0.0269828097897896,0.0124704655080759,0.470957388665421
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36036,0.00856064613432138,0.00750165327145949,-0.00614259427773922,0.023263886546382,0.253836796342548
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4122.Speed of sound through heel (right),36037,0.0015282184498703,0.00712055570116516,-0.0124280707244134,0.015484507624154,0.830068959919168
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36037,0.00444586439459046,0.00724416969282854,-0.00975270820335348,0.0186444369925344,0.539421642794454
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4124.Heel bone mineral density (BMD) (right),36026,0.00452072302300148,0.00727758933656416,-0.00974335207666427,0.0187847981226672,0.534497544316737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36037,0.00444414646908872,0.00724417578284179,-0.00975443806528119,0.0186427310034586,0.539578722254241
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4194.Pulse rate,36412,0.0250350965320942,0.00673356354626046,0.0118373119814237,0.0382328810827647,0.000202245935911087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4195.Pulse wave reflection index,36412,-0.00836943797760541,0.00707656520937274,-0.022239505787976,0.00550062983276517,0.23696493721046
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4196.Pulse wave peak to peak time,36404,-0.0129709500233202,0.00779763738476828,-0.028254319297466,0.00231241925082566,0.0962633105256448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4198.Position of the pulse wave peak,36412,0.0229776134726587,0.00843189499584183,0.00645109928080871,0.0395041276645087,0.00644284798151668
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4199.Position of pulse wave notch,36412,0.0188961947339302,0.00683921302399601,0.00549133720689804,0.0323010522609624,0.0057420954817998
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4200.Position of the shoulder on the pulse waveform,36412,0.0240269637588064,0.00858068877956424,0.00720881375086045,0.0408451137667523,0.00512089565624977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4269.Number of triplets attempted (left),36195,0.0811087079095704,0.112094226670555,-0.138595976364717,0.300813392183857,0.469348319018256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4270.Volume level set by participant (left),36109,0.0342912816761351,0.0340249696552602,-0.0323976588481748,0.100980222200445,0.313570028780268
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4276.Number of triplets attempted (right),36198,0.0425446970936142,0.110171126021953,-0.173390709909414,0.258480104096643,0.699382183945418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X4277.Volume level set by participant (right),36110,0.0752752418659286,0.0339927658577818,0.00864942078467619,0.141901062947181,0.0268278412149606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X4288.Time to answer,36377,0.00925762233178059,0.00805557800965284,-0.00653131056713898,0.0250465552307002,0.250501079749718
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Cognitive function,X4290.Duration screen displayed,36377,0.0128175372718071,0.00753098816587152,-0.00194319953330109,0.0275782740769153,0.08880042811902
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X46.Hand grip strength (left),51764,-0.0420144002716265,0.00561363593679811,-0.0530171267077508,-0.0310116738355023,7.44654326826499e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X47.Hand grip strength (right),51767,-0.0355902787975763,0.00553756804661524,-0.0464439121689422,-0.0247366454262105,1.32627596699044e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X48.Waist circumference,51824,0.105178885148342,0.0104798051368694,0.0846384670800779,0.125719303216606,1.17911290813306e-23
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X4803.Tinnitus,36228,0.0580471084277299,0.0383336553232903,-0.0170868560059191,0.133181072861379,0.130001439988626
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X4825.Noisy workplace,36305,0.0640384749596841,0.0368761259984796,-0.00823873199733594,0.136315681916704,0.0825006778932396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Working and living environment,X4836.Loud music exposure frequency,36256,0.0843366697678095,0.0487107872615094,-0.0111364732647489,0.179809812800368,0.0834250863919726
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X49.Hip circumference,51818,-0.0135973058624496,0.00775302438519466,-0.0287932336574312,0.00159862193253191,0.0794768331913441
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X50.Standing height,51776,-0.0116666966947091,0.00585897726052134,-0.0231502921253309,-0.000183101264087245,0.0464649742934031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X5057.Number of older siblings,35384,-0.0604301919704105,0.0361211366749746,-0.131227619853361,0.0103672359125398,0.0943759698428231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,X51.Seated height,51677,0.00241205409441814,0.00509228538915861,-0.00756882526833274,0.012392933457169,0.635740952626601
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5181.Ever had eye surgery,33829,0.0558441441793808,0.0820814557296439,-0.105035509050721,0.216723797409483,0.496312806311086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5186.Duration visual-acuity screen displayed (right),33819,-0.00247333886623972,0.00868321099068661,-0.0194924324079855,0.014545754675506,0.775776875977176
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5188.Duration visual-acuity screen displayed (left),33814,0.00305784899986254,0.00898022635382978,-0.0145433946536438,0.0206590926533689,0.73348687173357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5190.Duration at which refractometer first shown (right),33765,-0.00182747235824071,0.0090028516435824,-0.0194730615796622,0.0158181168631808,0.839152276314294
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5193.Duration at which refractometer first shown (left),33760,0.00115194276403088,0.00905052742984234,-0.0165870909984601,0.0188909765265219,0.898724480440309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5199.logMAR, initial (right)",33798,0.0480964170399236,0.0430054883296813,-0.0361943400862517,0.132387174166099,0.263457030065152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5200.Final number of letters displayed (right),33798,0.233593186241987,0.281018096298757,-0.317202282503577,0.784388654987551,0.40587685281562
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5201.logMAR, final (right)",33736,0.00918204603865395,0.00861268645471558,-0.00769881941258859,0.0260629114898965,0.286425350536545
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5202.Number of rounds to result (right),33798,0.0472212295301601,0.0407213809835057,-0.0325926771975111,0.127035136257831,0.24625791347213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5206.logMAR, initial (left)",33792,0.00266784113007192,0.0428776120875321,-0.081372278561491,0.0867079608216349,0.950390103410834
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5207.Final number of letters displayed (left),33792,0.0883912857587826,0.261210465064212,-0.423581225767073,0.600363797284639,0.735082199371871
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5208.logMAR, final (left)",33745,-0.00619974264604831,0.00870698468838955,-0.0232654326352918,0.0108659473431952,0.476470779488085
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5209.Number of rounds to result (left),33788,0.0309377166022958,0.0405903102184098,-0.0486192914257874,0.110494724630379,0.445978571773486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33598,-0.0127004892394591,0.00865571447144971,-0.0296656896035005,0.00426471112458237,0.142358659786689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33598,-0.00914169436232208,0.00849041617532301,-0.0257829100659552,0.00749952134131102,0.281662950006676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5256.Corneal hysteresis (right),33598,0.00895946499327008,0.00878919006972706,-0.00826734754339495,0.0261862775299351,0.308075153936934
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5257.Corneal resistance factor (right),33598,0.00270706046005041,0.00866392429099735,-0.0142742311503044,0.0196883520704052,0.754710072757049
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33572,0.000642552478820823,0.0087236030488396,-0.0164557094969048,0.0177408144545464,0.941286455721927
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33572,-0.00149766890096704,0.00865122127601247,-0.0184540626019515,0.0154587248000174,0.862566924901207
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5264.Corneal hysteresis (left),33572,0.00166323380656144,0.00869369396876095,-0.01537640637221,0.0187028739853329,0.848286644617322
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X5265.Corneal resistance factor (left),33572,0.00080066333651465,0.00865213087831676,-0.0161575131849862,0.0177588398580155,0.926273186228546
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34492,0.256944875087893,0.178592952908895,-0.0930973126135402,0.606987062789326,0.150283595720703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",51755,0.00860422341683879,0.0229284833595961,-0.0363356039679695,0.0535440508016471,0.707467929659451
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",51755,-0.0464316459705108,0.0266862430064337,-0.098736682263121,0.00587339032209932,0.0818882082695372
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",51755,0.0437317963153479,0.0648561214540357,-0.0833862017345621,0.170849794365258,0.500134062582941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",51755,-0.0407989319061796,0.0104079825168746,-0.0611985776392539,-0.0203992861731054,8.88164559903034e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",51755,0.0315690349808767,0.00965482275055813,0.0126455823897827,0.0504924875719706,0.00107792654525492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",38731,-0.0237970784991839,0.0125790394873711,-0.0484519958944314,0.000857838896063504,0.0585455786973121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",38731,-0.0678322550551517,0.0391614069527672,-0.144588612682576,0.00892410257227209,0.0832826409104034
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",38731,-0.0323009975626356,0.02439588443683,-0.0801169310588223,0.0155149359335511,0.185521391867621
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",38731,0.00871075872036625,0.0146033518290589,-0.0199118108645893,0.0373333283053218,0.550861013752048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,51823,-0.039878724016075,0.0221549881336815,-0.0833025007580906,0.00354505272594072,0.0718754261623839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,51823,-0.039878724016075,0.0221549881336815,-0.0833025007580906,0.00354505272594072,0.0718754261623839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),51823,-0.00873665355153143,0.0161238837731062,-0.0403394657468197,0.0228661586437568,0.58793015578716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',51823,-0.101407421681334,0.0284521990013962,-0.15717373172407,-0.0456411116385971,0.000365792935850711
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),51823,0.00198298953769075,0.065435570461336,-0.126270728566528,0.130236707641909,0.975824501152813
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),51823,-0.0258982439553892,0.0474296868630014,-0.118860430206872,0.0670639422960936,0.585047487806642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,51823,0.0837199622114024,0.0698134902655708,-0.0531144787091163,0.220554403131921,0.230464512611629
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,51754,-0.022051051408777,0.0142828033695334,-0.0500453460130624,0.00594324319550833,0.122629088601989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,51754,0.0447522244323135,0.0252041415130939,-0.00464789293335049,0.0941523417979775,0.0758136329457278
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,51754,0.0122420845411443,0.0130323280851728,-0.0133012785057945,0.037785447588083,0.347554291220364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,51754,0.0738501590344203,0.0193598037723769,0.0359049436405616,0.111795374428279,0.000136750586460656
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,51754,0.0756893503452719,0.0194748207557992,0.0375187016639055,0.113859999026638,0.000101973300524814
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,51754,0.0518468670729238,0.010990893035417,0.0303047167235064,0.0733890174223412,2.40439877129839e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,36969,0.0580671828262589,0.0207695627601441,0.0173588398163765,0.0987755258361413,0.00518922220684141
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,36969,0.0462566648347921,0.0197182258653443,0.0076089421387172,0.084904387530867,0.0190052415981243
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,36969,0.0503639838054427,0.0285196181142157,-0.00553446769842006,0.106262435309305,0.0774420789105416
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,36969,-0.0440289238465874,0.0213509994007747,-0.0858768826721059,-0.00218096502106898,0.0392244309827761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,51701,0.0118659731825289,0.0384475921672479,-0.063491307465277,0.0872232538303349,0.75760790145606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#2.Fractured bone site(s)_Leg,51701,0.00715561948502051,0.0482898796278485,-0.0874925445855625,0.101803783555604,0.882201598010522
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#3.Fractured bone site(s)_Hip,51701,0.0373700530739326,0.0960602760389605,-0.15090808796243,0.225648194110295,0.697259666135866
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#4.Fractured bone site(s)_Spine,51701,-0.110122558405232,0.0917489699585141,-0.28995053952392,0.0697054227134559,0.230050942668391
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,51701,-0.0320640989535722,0.0364389879215641,-0.103484515279838,0.0393563173726934,0.37890132557657
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#6.Fractured bone site(s)_Arm,51701,0.0199776548393471,0.0433132015265907,-0.0649162201527707,0.104871529831465,0.644632859846148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,51701,-0.0270170269789201,0.0181193888381003,-0.0625310291015966,0.00849697514375647,0.135960395797538
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35522,0.0366378870952307,0.0312571811378658,-0.0246261879349863,0.0979019621254477,0.241179975301147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35522,0.0478957458736543,0.0305493403670076,-0.0119809612456806,0.107772452992989,0.116969779669039
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35522,0.0733280950110601,0.0429861122428043,-0.0109246849848363,0.157580875006956,0.088079852462174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35522,0.0115906378721519,0.0156792291230089,-0.0191406512089455,0.0423219269532494,0.459789264406651
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38617,0.0163829214328054,0.0133101336401167,-0.00970494050182337,0.0424707833674341,0.218403839689119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38617,-0.0298383135821,0.0147096085614281,-0.0586691463624991,-0.00100748080170088,0.0425365292717867
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38617,0.0310811729595459,0.0130470195450014,0.00550901465134321,0.0566533312677487,0.0172260809142574
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38618,-0.0241795565615363,0.0301102836817418,-0.0831957125777502,0.0348365994546777,0.421974613925147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38618,0.00692807424501642,0.0181076047416034,-0.0285628310485263,0.0424189795385592,0.702020200472933
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38618,0.0966901236619583,0.0329253828878964,0.0321563732016813,0.161223874122235,0.00332539811014165
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,51754,-0.0149183120388577,0.0282419016392311,-0.0702724392517506,0.0404358151740353,0.597342503245467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,51754,0.0188377088675984,0.0227576207466161,-0.0257672277957691,0.0634426455309659,0.407818429905551
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,51754,0.0789530253813984,0.0448547281282675,-0.00896224175000596,0.166868292512803,0.078388112997239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,51754,0.00375964786299932,0.0253191613505481,-0.045865908384075,0.0533852041100737,0.88195719606491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,51754,-0.0307332514928083,0.0260794686761861,-0.081849010098133,0.0203825071125164,0.23863086799839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),51754,-0.0145907325155967,0.0312636435815801,-0.0758674739354938,0.0466860089043003,0.640719148432749
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,51754,-0.0218413060101437,0.00912024019422817,-0.0397169767908309,-0.00396563522945649,0.0166365619478706
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34086,0.00860954953937208,0.0232693123167504,-0.0369983026014586,0.0542174016802028,0.711399847452337
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34086,0.0520768193950678,0.0279620000857724,-0.00272870077304603,0.106882339563182,0.062598181014258
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34086,-0.0607822753456466,0.0207402594436538,-0.101433183855208,-0.0201313668360852,0.00339658088015729
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34086,0.036501166206777,0.0183772471409075,0.000481761810598197,0.0725205706029557,0.0470591242886409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,51858,0.0545145458022981,0.011105641398185,0.0327474886618556,0.0762816029427407,9.22906720283869e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,51858,0.0972853795874254,0.0363585427431902,0.0260226358107727,0.168548123364078,0.00746205224649251
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,51858,0.00811279290018392,0.00978261336621343,-0.0110611292975944,0.0272867150979622,0.406939039373456
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,51858,0.0144678459756714,0.00913817843257537,-0.0034429837521763,0.0323786757035192,0.113382454819433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,51858,0.0619103981080202,0.015461825274573,0.0316052205698571,0.0922155756461833,6.24523291913866e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,51858,0.0422026999563465,0.0139603802410331,0.0148403546839217,0.0695650452287714,0.00250526899485134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,51858,0.00854255663523776,0.00986297630341481,-0.0107888769194553,0.0278739901899308,0.386431313735027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,51858,0.111669845531067,0.0323172181683148,0.0483280979211703,0.175011593140964,0.000550398390922585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,44791,-0.0472610094470389,0.0101207244844225,-0.067097629436507,-0.0274243894575709,3.04023565842199e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,44791,-0.0446367739330845,0.00994511863472515,-0.0641292064571458,-0.0251443414090232,7.2285479796954e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,44791,0.0493596785141942,0.0128709182674133,0.0241326787100642,0.0745866783183243,0.000126051736848488
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,44792,0.0226095443798138,0.0199310904228053,-0.0164553928488846,0.0616744816085123,0.256649579260642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,44792,0.0493846348906644,0.0113572351733215,0.0271244539509542,0.0716448158303745,1.38036384840422e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,51637,0.0365428349568774,0.0104837397533952,0.0159947050402228,0.057090964873532,0.000491823355061113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,51637,-0.0185193710917732,0.00823706995404876,-0.0346640282017088,-0.00237471398183764,0.0245667385682137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,51637,-0.00146596448561276,0.00930708698200107,-0.0197078549703349,0.0167759259991093,0.874843866274822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,51637,-0.0487851746928815,0.0142145542653895,-0.0766457010530448,-0.0209246483327181,0.000600071303135363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),51660,-0.015465690022061,0.00887494434328249,-0.0328605809348946,0.00192920089077272,0.0814126646133445
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,51660,-0.0792679381164709,0.0123888626119934,-0.103550108835978,-0.0549857673969638,1.60110699898079e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),51754,0.0174411597046341,0.00904953088794342,-0.000295920835735007,0.0351782402450032,0.0539544892861955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,51754,-0.00485597447128162,0.0113691967180776,-0.0271396000387136,0.0174276510961504,0.669298257364491
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,51754,0.015040227420856,0.0241242288151354,-0.0322432610568094,0.0623237158985213,0.532995618082099
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,51754,-0.0335119817178489,0.0220889037221243,-0.0768062330132124,0.0097822695775147,0.129244738179409
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,51754,0.057046830337981,0.0268370921407097,0.00444612974218997,0.109647530933772,0.0335412113151838
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,51754,-0.0322297503275527,0.0278197990657419,-0.0867565564964068,0.0222970558413013,0.24666447805313
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",41775,-0.0171898761252608,0.00545540374372922,-0.02788246746297,-0.00649728478755148,0.00163087089249439
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X864.Number of days or week walked 10+ minutes,51396,-0.0729091208487674,0.0196298868277748,-0.111383699031206,-0.0344345426663288,0.000204342213421996
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X874.Duration of walks,48805,-0.0154931777813408,0.00423745495795951,-0.0237985894989414,-0.00718776606374017,0.000256584934137407
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,50814,-0.104972772411602,0.0189998273125211,-0.142212433944143,-0.0677331108790604,3.33309615265607e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X894.Duration of moderate activity,46106,-0.0993029737411038,0.0229625423768142,-0.14430955679966,-0.054296390682548,1.53679438219017e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X90087.No-wear time bias adjusted average acceleration,33224,-0.0257725271030312,0.00948298241081204,-0.0443591726282228,-0.00718588157783958,0.00659692688484691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,50737,-0.158789112964514,0.0195742573639775,-0.19715465739791,-0.120423568531118,5.23015705919974e-16
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Physical activities,X914.Duration of vigorous activity,41846,-0.015920028917941,0.00507363772116122,-0.025864358851417,-0.00597569898446501,0.00170597813959142
